The	O
proximal	O
regulatory	O
element	O
of	O
the	O
interferon-gamma	B-DNA
promoter	I-DNA
mediates	O
selective	O
expression	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

Interferon-gamma	B-protein
(	O
IFN-gamma	B-protein
)	O
is	O
produced	O
by	O
natural	B-cell_type
killer	I-cell_type
cells	I-cell_type
and	O
certain	O
subsets	O
of	O
T	B-cell_type
cells	I-cell_type
,	O
but	O
the	O
basis	O
for	O
its	O
selective	O
expression	O
is	O
unknown	O
.	O

Within	O
the	O
region	O
between	O
-108	O
and	O
-40	O
base	O
pairs	O
of	O
the	O
IFN-gamma	B-protein
promoter	O
are	O
two	O
conserved	O
and	O
essential	O
regulatory	B-DNA
elements	I-DNA
,	O
which	O
confer	O
activation-specific	O
expression	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

This	O
report	O
describes	O
studies	O
indicating	O
that	O
the	O
most	O
proximal	O
of	O
these	O
two	O
regulatory	B-DNA
elements	I-DNA
is	O
an	O
important	O
determinant	O
of	O
its	O
restricted	O
expression	O
.	O

The	O
proximal	O
element	O
is	O
a	O
composite	O
site	O
that	O
binds	O
members	O
of	O
the	O
CREB/ATF	B-protein
,	O
AP-1	B-protein
,	O
and	O
octamer	B-protein
families	I-protein
of	O
transcription	B-protein
factors	I-protein
.	O

Jun	B-protein
is	O
essential	O
for	O
activation-induced	O
transcription	O
and	O
binds	O
preferably	O
as	O
a	O
heterodimer	O
with	O
ATF-2	B-protein
.	O

In	O
contrast	O
,	O
CREB	B-protein
appears	O
to	O
dampen	O
transcription	O
from	O
this	O
element	O
.	O

The	O
CpG	O
dinucleotide	O
in	O
this	O
element	B-DNA
is	O
selectively	O
methylated	O
in	O
Th2	B-cell_type
T	I-cell_type
cells	I-cell_type
and	O
other	O
cells	O
that	O
do	O
not	O
express	O
IFN-gamma	B-protein
,	O
and	O
methylation	O
markedly	O
reduces	O
transcription	B-protein
factor	I-protein
binding	O
.	O

As	O
a	O
target	O
for	O
DNA	O
methylation	O
and	O
for	O
binding	O
of	O
transcription	B-protein
factors	I-protein
that	O
mediate	O
or	O
impede	O
transcription	O
,	O
this	O
element	O
appears	O
to	O
play	O
a	O
central	O
role	O
in	O
controlling	O
IFN-gamma	B-protein
expression	O
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

271	NULL
,	NULL
No	NULL
.	NULL

50	NULL
,	NULL
Issue	NULL
of	NULL
December	NULL
13	NULL
,	NULL
pp	NULL
.	NULL

31964-31972	NULL
,	NULL
1996	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

The	NULL
Proximal	NULL
Regulatory	NULL
Element	NULL
of	NULL
the	NULL
Interferon-y	NULL
Promoter	NULL
Mediates	NULL
Selective	NULL
Expression	NULL
in	NULL
T	NULL
Cells*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
July	NULL
30	NULL
,	NULL
1996	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
September	NULL
26	NULL
,	NULL
1996	NULL
)	NULL
Laurie	NULL
A.	NULL
Penix	NULL
}	NULL
§	NULL
,	NULL
Marianne	NULL
T.	NULL
Sweetser§1	NULL
,	NULL
William	NULL
M.	NULL
Weaver1	NULL
,	NULL
James	NULL
P.	NULL
Hoeffler	NULL
)	NULL
,	NULL
Tom	NULL
K.	NULL
Kerppola**	NULL
,	NULL
and	NULL
Christopher	NULL
B.	NULL
Wilsont	NULL
#	NULL
#	NULL
§§	NULL
From	NULL
the	NULL
{	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Yale	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
Connecticut	NULL
06520-8064	NULL
,	NULL
the	NULL
Departments	NULL
of	NULL
Pediatrics	NULL
and	NULL
University	NULL
of	NULL
Washington	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Seattle	NULL
,	NULL
Washington	NULL
98195	NULL
,	NULL
|Invitrogen	NULL
Corporation	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
California	NULL
92121	NULL
,	NULL
and	NULL
the	NULL
**Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
and	NULL
Department	NULL
of	NULL
Biological	NULL
Chemistry	NULL
,	NULL
University	NULL
of	NULL
Michigan	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
Michigan	NULL
48109-0650	NULL
Interferon-y	NULL
(	NULL
IFN-y	NULL
)	NULL
is	NULL
produced	NULL
by	NULL
natural	NULL
killer	NULL
cells	NULL
and	NULL
certain	NULL
subsets	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
the	NULL
basis	NULL
for	NULL
its	NULL
selective	NULL
expression	NULL
is	NULL
unknown	NULL
.	NULL

Within	NULL
the	NULL
region	NULL
between	NULL
-108	NULL
and	NULL
-40	NULL
base	NULL
pairs	NULL
of	NULL
the	NULL
IFN-y	NULL
promoter	NULL
are	NULL
two	NULL
conserved	NULL
and	NULL
essential	NULL
regulatory	NULL
elements	NULL
,	NULL
which	NULL
confer	NULL
activation-specific	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
report	NULL
describes	NULL
studies	NULL
indicating	NULL
that	NULL
the	NULL
most	NULL
proximal	NULL
of	NULL
these	NULL
two	NULL
regulatory	NULL
elements	NULL
is	NULL
an	NULL
important	NULL
determinant	NULL
of	NULL
its	NULL
restricted	NULL
expression	NULL
.	NULL

The	NULL
proximal	NULL
element	NULL
is	NULL
a	NULL
composite	NULL
site	NULL
that	NULL
binds	NULL
members	NULL
of	NULL
the	NULL
CREB/ATF	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
octamer	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Jun	NULL
is	NULL
essential	NULL
for	NULL
activation-induced	NULL
transcription	NULL
and	NULL
binds	NULL
preferably	NULL
as	NULL
a	NULL
heterodimer	NULL
with	NULL
ATF-2	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CREB	NULL
appears	NULL
to	NULL
dampen	NULL
transcription	NULL
from	NULL
this	NULL
element	NULL
.	NULL

The	NULL
CpG	NULL
dinucleotide	NULL
in	NULL
this	NULL
element	NULL
is	NULL
selectively	NULL
methylated	NULL
in	NULL
Th2	NULL
T	NULL
cells	NULL
and	NULL
other	NULL
cells	NULL
that	NULL
do	NULL
not	NULL
express	NULL
IFN-y	NULL
,	NULL
and	NULL
methylation	NULL
markedly	NULL
reduces	NULL
transcription	NULL
factor	NULL
binding	NULL
.	NULL

As	NULL
a	NULL
target	NULL
for	NULL
DNA	NULL
methylation	NULL
and	NULL
for	NULL
binding	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
mediate	NULL
or	NULL
impede	NULL
transcription	NULL
,	NULL
this	NULL
element	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
controlling	NULL
IFN-y	NULL
expression	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
lymphokines	NULL
by	NULL
individual	NULL
T	NULL
cells	NULL
is	NULL
central	NULL
to	NULL
the	NULL
proper	NULL
regulation	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
and	NULL
in	NULL
resistance	NULL
to	NULL
infection	NULL
.	NULL

For	NULL
example	NULL
,	NULL
production	NULL
of	NULL
interferon-y	NULL
(	NULL
IFN-	NULL
'	NULL
y	NULL
)	NULL
1	NULL
facilitates	NULL
host	NULL
defense	NULL
to	NULL
intracellular	NULL
patho-gens	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IL-4	NULL
appears	NULL
to	NULL
antagonize	NULL
host	NULL
defense	NULL
to	NULL
such	NULL
agents	NULL
while	NULL
contributing	NULL
to	NULL
protection	NULL
from	NULL
intestinal	NULL
helminths	NULL
and	NULL
facilitating	NULL
the	NULL
development	NULL
of	NULL
allergic	NULL
responses	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
abnormal	NULL
regulation	NULL
of	NULL
lymphokine	NULL
production	NULL
contributes	NULL
to	NULL
the	NULL
pathogenesis	NULL
of	NULL
certain	NULL
infectious	NULL
,	NULL
allergic	NULL
,	NULL
and	NULL
autoimmune	NULL
diseases	NULL
.	NULL

Since	NULL
the	NULL
production	NULL
of	NULL
these	NULL
and	NULL
other	NULL
cytokines	NULL
by	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
activation	NULL
is	NULL
predominantly	NULL
regulated	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
(	NULL
3-5	NULL
)	NULL
,	NULL
it	NULL
follows	NULL
that	NULL
differential	NULL
transcription	NULL
of	NULL
lympho-	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
Grants	NULL
AIO1117	NULL
and	NULL
HD94022	NULL
(	NULL
to	NULL
L.	NULL
A.	NULL
P.	NULL
)	NULL
,	NULL
AIO7411	NULL
and	NULL
HD28834	NULL
(	NULL
to	NULL
M.	NULL
T.	NULL
S.	NULL
)	NULL
,	NULL
HD18184	NULL
and	NULL
A137107	NULL
(	NULL
to	NULL
C.	NULL
B.	NULL
W.	NULL
)	NULL
,	NULL
and	NULL
DKA47120	NULL
(	NULL
to	NULL
J.	NULL
P.	NULL
H.	NULL
)	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1784	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
Contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

§§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Pediatrics	NULL
,	NULL
P.	NULL
0	NULL
.	NULL

Box	NULL
356320	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
98195	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
206-543-3207	NULL
;	NULL
Fax	NULL
:	NULL
206-548-3184	NULL
;	NULL
E-mail	NULL
:	NULL
cbwilson	NULL
@	NULL
u.washington.edu	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IFN-y	NULL
,	NULL
interferon-y	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
GST	NULL
,	NULL
glutathione	NULL
S-transferase	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
18-acetate	NULL
;	NULL
RSV	NULL
,	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
.	NULL

31964	NULL
kine	NULL
genes	NULL
is	NULL
essential	NULL
to	NULL
a	NULL
properly	NULL
regulated	NULL
immune	NULL
response	NULL
.	NULL

Activation	NULL
of	NULL
T	NULL
cells	NULL
leads	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
intracellular	NULL
Ca	NULL
``	NULL
*	NULL
,	NULL
which	NULL
activates	NULL
calcineurin	NULL
,	NULL
and	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
c-Jun	NULL
amino-terminal/stress-activated	NULL
protein	NULL
kinases	NULL
are	NULL
trig-gered	NULL
.	NULL

Recent	NULL
work	NULL
has	NULL
established	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
these	NULL
events	NULL
lead	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
IL-2	NULL
and	NULL
IL-4	NULL
transcription	NULL
.	NULL

Both	NULL
promoters	NULL
contain	NULL
regulatory	NULL
elements	NULL
that	NULL
engage	NULL
one	NULL
or	NULL
more	NULL
NFAT	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
)	NULL
proteins	NULL
(	NULL
6-11	NULL
)	NULL
.	NULL

Preformed	NULL
NFAT	NULL
resides	NULL
in	NULL
the	NULL
cytosol	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
and	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
on	NULL
activation	NULL
;	NULL
this	NULL
translocation	NULL
is	NULL
regulated	NULL
by	NULL
calcineurin	NULL
,	NULL
the	NULL
action	NULL
of	NULL
which	NULL
is	NULL
inhibited	NULL
by	NULL
cyclosporin	NULL
(	NULL
7	NULL
,	NULL
9	NULL
,	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Calcineurin	NULL
also	NULL
acts	NULL
in	NULL
concert	NULL
with	NULL
protein	NULL
kinase	NULL
C	NULL
to	NULL
activate	NULL
c-Jun	NULL
amino-terminal	NULL
kinases	NULL
,	NULL
which	NULL
phosphorylate	NULL
Jun	NULL
and	NULL
ATF-2	NULL
(	NULL
activating	NULL
transcription	NULL
factor	NULL
)	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Jun	NULL
and	NULL
Fos	NULL
(	NULL
AP-1	NULL
(	NULL
activator	NULL
Brotein	NULL
»	NULL
proteins	NULL
bind	NULL
in	NULL
concert	NULL
with	NULL
NFAT	NULL
to	NULL
multiple	NULL
sites	NULL
in	NULL
the	NULL
IL-2	NULL
(	NULL
10	NULL
,	NULL
15	NULL
,	NULL
16	NULL
)	NULL
and	NULL
IL-4	NULL
(	NULL
9	NULL
,	NULL
17	NULL
)	NULL
promoters	NULL
and	NULL
thereby	NULL
contribute	NULL
to	NULL
transcriptional	NULL
activation	NULL
.	NULL

However	NULL
,	NULL
the	NULL
transcription	NULL
factors	NULL
binding	NULL
to	NULL
these	NULL
elements	NULL
are	NULL
common	NULL
to	NULL
cell	NULL
types	NULL
other	NULL
than	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
distal	NULL
NFAT	NULL
site	NULL
and	NULL
the	NULL
P1	NULL
NFAT	NULL
site	NULL
can	NULL
be	NULL
exchanged	NULL
between	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
promoters	NULL
without	NULL
affecting	NULL
specificity	NULL
of	NULL
promoter	NULL
function	NULL
for	NULL
Th1	NULL
(	NULL
T	NULL
helper	NULL
lympho-cytes	NULL
)	NULL
and	NULL
Th2	NULL
T	NULL
cell	NULL
clones	NULL
,	NULL
respectively	NULL
(	NULL
9	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
elements	NULL
are	NULL
sufficient	NULL
to	NULL
account	NULL
for	NULL
activation-specific	NULL
,	NULL
cyclosporin-sensitive	NULL
promoter	NULL
function	NULL
,	NULL
but	NULL
not	NULL
for	NULL
specificity	NULL
of	NULL
their	NULL
promoters	NULL
.	NULL

Like	NULL
IL-2	NULL
,	NULL
IFN-y	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
Th1	NULL
subset	NULL
of	NULL
primed	NULL
CD4*	NULL
T	NULL
cells	NULL
,	NULL
whereas	NULL
IL-4	NULL
is	NULL
expressed	NULL
by	NULL
Th2	NULL
cells	NULL
.	NULL

IFN-y	NULL
expression	NULL
does	NULL
not	NULL
completely	NULL
parallel	NULL
that	NULL
of	NULL
IL-2	NULL
since	NULL
IFN-y	NULL
is	NULL
expressed	NULL
by	NULL
primed	NULL
but	NULL
not	NULL
naive	NULL
T	NULL
cells	NULL
and	NULL
,	NULL
among	NULL
primed	NULL
T	NULL
cells	NULL
,	NULL
also	NULL
is	NULL
highly	NULL
expressed	NULL
by	NULL
the	NULL
CD8*	NULL
subset	NULL
,	NULL
whereas	NULL
IL-2	NULL
is	NULL
not	NULL
(	NULL
2	NULL
,	NULL
4	NULL
,	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Despite	NULL
its	NULL
importance	NULL
in	NULL
regulation	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
,	NULL
compared	NULL
with	NULL
IL-2	NULL
and	NULL
IL-4	NULL
,	NULL
little	NULL
information	NULL
exists	NULL
regarding	NULL
the	NULL
regulation	NULL
of	NULL
IFN-y	NULL
expression	NULL
.	NULL

We	NULL
recently	NULL
reported	NULL
that	NULL
the	NULL
proximal	NULL
108	NULL
bp	NULL
of	NULL
5'-flanking	NULL
sequence	NULL
from	NULL
the	NULL
IFN-y	NULL
gene	NULL
are	NULL
necessary	NULL
and	NULL
sufficient	NULL
to	NULL
confer	NULL
T	NULL
cell	NULL
and	NULL
activation-specific	NULL
,	NULL
cyclosporin-sensitive	NULL
expression	NULL
and	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
region	NULL
is	NULL
associated	NULL
with	NULL
two	NULL
essential	NULL
and	NULL
evolutionarily	NULL
conserved	NULL
elements	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
proximal	NULL
element	NULL
(	NULL
-73	NULL
to	NULL
-48	NULL
bp	NULL
)	NULL
shares	NULL
homology	NULL
with	NULL
the	NULL
NFIL-2A	NULL
element	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
21	NULL
)	NULL
and	NULL
is	NULL
a	NULL
target	NULL
for	NULL
methylation	NULL
at	NULL
its	NULL
central	NULL
CpG	NULL
dinucleotide	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Methylation	NULL
at	NULL
this	NULL
site	NULL
correlates	NULL
strongly	NULL
and	NULL
inversely	NULL
with	NULL
the	NULL
capacity	NULL
of	NULL
primary	NULL
T	NULL
cell	NULL
populations	NULL
and	NULL
Th1	NULL
and	NULL
Th2	NULL
T	NULL
cell	NULL
clones	NULL
to	NULL
express	NULL
IFN-y	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
is	NULL
likely	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
and	NULL
perhaps	NULL
the	NULL
specificity	NULL
of	NULL
this	NULL
lympho-kine	NULL
's	NULL
expression	NULL
.	NULL

This	NULL
work	NULL
indicates	NULL
that	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
,	NULL
like	NULL
This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www-jbc.stanford.edu/jbc/	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Control	NULL
of	NULL
IFN-y	NULL
Expression	NULL
0.035	NULL
@	NULL
uns	NULL
0.030	NULL
|	NULL
|Giono	NULL
G	NULL
PMA	NULL
0.025	NULL
|	NULL
|	NULL
@	NULL
P	NULL
g	NULL
0.020	NULL
|	NULL
Lol	NULL
2	NULL
B	NULL
.	NULL

0.015	NULL
4	NULL
o	NULL
0.010	NULL
{	NULL
0.005	NULL
0.000	NULL
pEQs	NULL
pIFN-39	NULL
pIFN-538	NULL
Proximal	NULL
dimer	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Activation	NULL
requirements	NULL
of	NULL
the	NULL
proximal	NULL
element	NULL
of	NULL
the	NULL
IFN-y	NULL
promoter	NULL
.	NULL

Constructs	NULL
containing	NULL
no	NULL
promoter	NULL
(	NULL
pEQ3	NULL
)	NULL
,	NULL
the	NULL
basal	NULL
(	NULL
pIFN-39	NULL
)	NULL
or	NULL
full-length	NULL
(	NULL
pIFN-538	NULL
)	NULL
IFN-y	NULL
promoter	NULL
,	NULL
or	NULL
the	NULL
proximal	NULL
element	NULL
dimer	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
unstimulated	NULL
(	NULL
uns	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
1.5	NULL
uM	NULL
ionomycin	NULL
(	NULL
tono	NULL
,	NULL
I	NULL
)	NULL
and/or	NULL
25	NULL
ng/ml	NULL
PMA	NULL
(	NULL
P	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
500	NULL
ng/ml	NULL
cyclosporin	NULL
A	NULL
(	NULL
CSA	NULL
)	NULL
.	NULL

Values	NULL
are	NULL
the	NULL
means	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
two	NULL
experiments	NULL
.	NULL

CPR	NULL
,	NULL
chlorophenol	NULL
red	NULL
production	NULL
.	NULL

elements	NULL
defined	NULL
in	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
promoters	NULL
,	NULL
is	NULL
a	NULL
composite	NULL
binding	NULL
site	NULL
for	NULL
a	NULL
complex	NULL
array	NULL
of	NULL
transcription	NULL
factors	NULL
including	NULL
ATF-2	NULL
,	NULL
c-Jun	NULL
and	NULL
other	NULL
Jun	NULL
proteins	NULL
,	NULL
CREB	NULL
(	NULL
cAMP	NULL
response	NULL
element-binding	NULL
protein	NULL
)	NULL
,	NULL
ATF-1	NULL
,	NULL
and	NULL
Oct-1	NULL
(	NULL
octamer	NULL
)	NULL
.	NULL

c-Jun	NULL
engages	NULL
this	NULL
element	NULL
,	NULL
preferentially	NULL
as	NULL
a	NULL
heterodimer	NULL
with	NULL
ATF-2	NULL
,	NULL
and	NULL
activates	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CREB	NULL
and	NULL
ATF-1	NULL
,	NULL
which	NULL
are	NULL
cAMP-	NULL
and	NULL
calcium/calmodulin-responsive	NULL
transcription	NULL
factors	NULL
(	NULL
24	NULL
)	NULL
,	NULL
also	NULL
bind	NULL
to	NULL
this	NULL
element	NULL
with	NULL
high	NULL
affinity	NULL
,	NULL
and	NULL
CREB	NULL
impedes	NULL
transcription	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
methylation	NULL
of	NULL
the	NULL
central	NULL
CpG	NULL
dinucleotide	NULL
of	NULL
this	NULL
element	NULL
diminishes	NULL
transcription	NULL
factor	NULL
bind-ing	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
inverse	NULL
relationship	NULL
between	NULL
methylation	NULL
of	NULL
this	NULL
element	NULL
and	NULL
expression	NULL
of	NULL
IFN-y	NULL
by	NULL
T	NULL
cell	NULL
subsets	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
the	NULL
proximal	NULL
element	NULL
of	NULL
the	NULL
IFN-y	NULL
promoter	NULL
,	NULL
through	NULL
competitive	NULL
engagement	NULL
of	NULL
transcription	NULL
factors	NULL
and	NULL
differential	NULL
methylation	NULL
,	NULL
is	NULL
likely	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
selective	NULL
expression	NULL
of	NULL
IFN-y	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cell	NULL
Lines	NULL
and	NULL
Reagents-The	NULL
line	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
which	NULL
expresses	NULL
IFN-y	NULL
following	NULL
activation	NULL
)	NULL
,	NULL
the	NULL
human	NULL
monocyte-macrophage	NULL
cell	NULL
line	NULL
U937	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Epstein-Barr	NULL
virus-transformed	NULL
B	NULL
cell	NULL
line	NULL
816	NULL
(	NULL
D.	NULL
Pious	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
)	NULL
were	NULL
maintained	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
,	NULL
except	NULL
that	NULL
the	NULL
816	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
medium	NULL
supplemented	NULL
with	NULL
15	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Hyclone	NULL
Laboratories	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
.	NULL

L929	NULL
murine	NULL
fibroblasts	NULL
were	NULL
grown	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
following	NULL
antibodies	NULL
to	NULL
transcription	NULL
factors	NULL
were	NULL
used	NULL
.	NULL

For	NULL
the	NULL
CREB/ATF	NULL
family	NULL
,	NULL
anti-CREB-1	NULL
(	NULL
C-21	NULL
)	NULL
,	NULL
anti-ATF-1	NULL
(	NULL
C41-5.1	NULL
)	NULL
,	NULL
anti-CREB-1/ATF-1/CREM	NULL
(	NULL
25C10G	NULL
)	NULL
,	NULL
and	NULL
anti-ATF-4	NULL
(	NULL
25	NULL
)	NULL
were	NULL
mouse	NULL
monoclonal	NULL
antibodies	NULL
,	NULL
and	NULL
anti-ATF-3	NULL
(	NULL
C-19	NULL
)	NULL
was	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
monoclonal	NULL
(	NULL
F2BR1	NULL
)	NULL
and	NULL
rabbit	NULL
polyclonal	NULL
(	NULL
F2poly	NULL
)	NULL
antibodies	NULL
to	NULL
human	NULL
ATF-2	NULL
were	NULL
provided	NULL
by	NULL
J.	NULL
P.	NULL
Hoeffler	NULL
(	NULL
Invitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

For	NULL
the	NULL
AP-1	NULL
and	NULL
octamer	NULL
families	NULL
,	NULL
rabbit	NULL
polyclonal	NULL
anti-Jun	NULL
[	NULL
D	NULL
]	NULL
)	NULL
,	NULL
anti-c-Jun-specific	NULL
(	NULL
c-Jun/AP-1	NULL
[	NULL
N	NULL
]	NULL
)	NULL
,	NULL
anti-Fos	NULL
(	NULL
K-25	NULL
)	NULL
,	NULL
and	NULL
anti-Oct-l	NULL
were	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

Plasmid	NULL
Constructs-The	NULL
pIFN-588-	NULL
,	NULL
pIFN-108-	NULL
,	NULL
pIFN-89-	NULL
,	NULL
and	NULL
plIL2-568-6-galactosidase	NULL
reporter	NULL
and	NULL
B-actin-CAT	NULL
constructs	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Plasmids	NULL
containing	NULL
head-to-tail	NULL
(	NULL
5	NULL
'	NULL
to	NULL
3	NULL
``	NULL
)	NULL
dimers	NULL
of	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
(	NULL
-71	NULL
to	NULL
-44	NULL
bp	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
)	NULL
were	NULL
generated	NULL
by	NULL
subcloning	NULL
ligated	NULL
oligomers	NULL
synthesized	NULL
with	NULL
terminal	NULL
Bg/II	NULL
(	NULL
5	NULL
'	NULL
)	NULL
and	NULL
BamHI	NULL
(	NULL
8	NULL
'	NULL
)	NULL
restriction	NULL
sites	NULL
into	NULL
the	NULL
pIFN-89	NULL
basal	NULL
promoter	NULL
construct	NULL
.	NULL

Proximal	NULL
dimers	NULL
with	NULL
mutations	NULL
M1-M4	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
were	NULL
produced	NULL
in	NULL
a	NULL
similar	NULL
manner	NULL
.	NULL

The	NULL
full-length	NULL
promoter	NULL
(	NULL
pIFN-588	NULL
)	NULL
containing	NULL
the	NULL
M5	NULL
(	NULL
C	NULL
to	NULL
T	NULL
)	NULL
mutation	NULL
31965	NULL
was	NULL
prepared	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
site-directed	NULL
mutagenesis	NULL
and	NULL
splicing	NULL
by	NULL
overlap	NULL
extension	NULL
(	NULL
26	NULL
)	NULL
to	NULL
generate	NULL
a	NULL
240-bp	NULL
fragment	NULL
that	NULL
was	NULL
subcloned	NULL
into	NULL
pIFN-588A-177/-109	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
each	NULL
construct	NULL
was	NULL
confirmed	NULL
with	NULL
dideoxynucleotide	NULL
chain	NULL
termination	NULL
sequencing	NULL
.	NULL

Plasmids	NULL
containing	NULL
the	NULL
cDNAs	NULL
for	NULL
CREB	NULL
and	NULL
CREB	NULL
containing	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
DNA-binding	NULL
domain	NULL
that	NULL
allows	NULL
dimerization	NULL
but	NULL
blocks	NULL
binding	NULL
to	NULL
target	NULL
DNA	NULL
(	NULL
KCREB	NULL
)	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
R.	NULL
H.	NULL
Goodman	NULL
(	NULL
Vollum	NULL
Institute	NULL
,	NULL
Oregon	NULL
Health	NULL
Sciences	NULL
University	NULL
,	NULL
Portland	NULL
,	NULL
OR	NULL
)	NULL
.	NULL

Plasmids	NULL
containing	NULL
cDNAs	NULL
for	NULL
murine	NULL
ATF-2	NULL
(	NULL
CRE-BP2.1	NULL
)	NULL
and	NULL
murine	NULL
ATF-2	NULL
with	NULL
a	NULL
mutation	NULL
abrogating	NULL
DNA	NULL
binding	NULL
(	NULL
CRE-BP1mu	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
K.	NULL
Georgopoulos	NULL
(	NULL
Massachusetts	NULL
General	NULL
Hospital	NULL
,	NULL
Charlestown	NULL
,	NULL
MA	NULL
)	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Plasmids	NULL
containing	NULL
wild-type	NULL
human	NULL
ATF-2	NULL
(	NULL
ATF-2FL	NULL
)	NULL
and	NULL
a	NULL
truncated	NULL
form	NULL
lacking	NULL
the	NULL
transcriptional	NULL
activation	NULL
domain	NULL
(	NULL
ATF-2BR	NULL
)	NULL
(	NULL
80	NULL
)	NULL
and	NULL
wild-type	NULL
c-Jun	NULL
(	NULL
81	NULL
,	NULL
32	NULL
)	NULL
have	NULL
been	NULL
described	NULL
;	NULL
the	NULL
plasmid	NULL
containing	NULL
c-Jun	NULL
with	NULL
a	NULL
deletion	NULL
of	NULL
residues	NULL
260-266	NULL
in	NULL
the	NULL
DNA-binding	NULL
domain	NULL
(	NULL
c-JunABR	NULL
)	NULL
was	NULL
analogous	NULL
to	NULL
that	NULL
described	NULL
in	NULL
Ref	NULL
.	NULL

33	NULL
.	NULL

These	NULL
cDNAs	NULL
were	NULL
received	NULL
or	NULL
cloned	NULL
into	NULL
the	NULL
pReRSV	NULL
vector	NULL
(	NULL
Invitrogen	NULL
)	NULL
.	NULL

Transient	NULL
Transfection	NULL
Assays-Jurkat	NULL
,	NULL
U9837	NULL
,	NULL
and	NULL
816	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
both	NULL
30	NULL
ug	NULL
of	NULL
IFN-y	NULL
B-galactosidase	NULL
plasmid	NULL
and	NULL
16	NULL
ug	NULL
of	NULL
control	NULL
B-actin-CAT	NULL
plasmid	NULL
in	NULL
0.5	NULL
ml	NULL
of	NULL
RPMI	NULL
1640	NULL
medium	NULL
by	NULL
electroporation	NULL
(	NULL
ECM600	NULL
,	NULL
BTX	NULL
Inc.	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
at	NULL
250	NULL
V	NULL
,	NULL
186	NULL
ohms	NULL
,	NULL
and	NULL
1900	NULL
,	NULL
1500	NULL
,	NULL
or	NULL
1050	NULL
microfarads	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
cotransfection	NULL
experiments	NULL
,	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
expression	NULL
plasmids	NULL
containing	NULL
transcription	NULL
factor	NULL
cDNAs	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
RSV	NULL
(	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
)	NULL
promoter	NULL
were	NULL
also	NULL
included	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
RSV	NULL
vector	NULL
per	NULL
cuvette	NULL
was	NULL
kept	NULL
constant	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
control	NULL
pRcRSV	NULL
plasmid	NULL
lacking	NULL
a	NULL
cDNA	NULL
insert	NULL
.	NULL

After	NULL
electroporation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
and	NULL
phorbol	NULL
12-myristate	NULL
18-acetate	NULL
(	NULL
PMA	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
cells	NULL
were	NULL
pretreated	NULL
for	NULL
20	NULL
min	NULL
with	NULL
cyclosporin	NULL
A	NULL
(	NULL
500	NULL
ng/ml	NULL
)	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
analyzed	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
using	NULL
chlorophenol	NULL
red	NULL
as	NULL
substrate	NULL
(	NULL
34	NULL
)	NULL
and	NULL
corrected	NULL
for	NULL
transfection	NULL
efficiency	NULL
by	NULL
normalizing	NULL
to	NULL
CAT	NULL
content	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
.	NULL

L929	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
IFN-y	NULL
B-galactosidase	NULL
plasmid	NULL
and	NULL
2.5	NULL
ug	NULL
of	NULL
control	NULL
B-actin-CAT	NULL
plasmid	NULL
using	NULL
400	NULL
ug/ml	NULL
DEAE-dextran	NULL
for	NULL
3	NULL
h	NULL
and	NULL
then	NULL
shocked	NULL
with	NULL
10	NULL
%	NULL
dimethyl	NULL
sulfoxide	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
for	NULL
1-2	NULL
min	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
stimulated	NULL
,	NULL
and	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assays-Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
that	NULL
were	NULL
untreated	NULL
or	NULL
stimulated	NULL
for	NULL
2	NULL
h	NULL
as	NULL
described	NULL
(	NULL
21	NULL
,	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

CREB-1	NULL
(	NULL
the	NULL
DNA-binding	NULL
domain	NULL
,	NULL
amino	NULL
acids	NULL
254-827	NULL
)	NULL
,	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
as	NULL
well	NULL
as	NULL
recombinant	NULL
c-Jun	NULL
(	NULL
the	NULL
DNA-binding	NULL
domain	NULL
,	NULL
amino	NULL
acids	NULL
199-834	NULL
)	NULL
and	NULL
c-Fos	NULL
(	NULL
the	NULL
DNA-binding	NULL
domain	NULL
,	NULL
amino	NULL
acids	NULL
139-200	NULL
)	NULL
,	NULL
provided	NULL
by	NULL
T.	NULL
K.	NULL
Kerppola	NULL
(	NULL
82	NULL
)	NULL
,	NULL
were	NULL
purified	NULL
by	NULL
nickel	NULL
chelate	NULL
affinity	NULL
chromatography	NULL
of	NULL
bacterial	NULL
lysates	NULL
(	NULL
87	NULL
)	NULL
.	NULL

Recombinant	NULL
ATF-1	NULL
(	NULL
full-length	NULL
)	NULL
and	NULL
ATF-2BR	NULL
(	NULL
the	NULL
DNA-binding	NULL
domain	NULL
,	NULL
amino	NULL
acids	NULL
350-505	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
boiling	NULL
lysis	NULL
preparations	NULL
of	NULL
bacteria	NULL
without	NULL
further	NULL
purification	NULL
and	NULL
are	NULL
~90	NULL
%	NULL
pure	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Sequences	NULL
of	NULL
oligonucleotides	NULL
used	NULL
(	NULL
with	NULL
their	NULL
consensus	NULL
sequences	NULL
underlined	NULL
)	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
(	NULL
-71	NULL
to	NULL
-47	NULL
bp	NULL
)	NULL
,	NULL
5'-AAAACTTGTGAAAATACGTAATCCT-3	NULL
'	NULL
;	NULL
the	NULL
NFIL-2A	NULL
element	NULL
(	NULL
36	NULL
)	NULL
,	NULL
5-GAAAATATGTGTAATATGTAAAACAT-3	NULL
'	NULL
;	NULL
the	NULL
consensus	NULL
so-matostatin	NULL
CRE	NULL
(	NULL
cAMP	NULL
response	NULL
element	NULL
)	NULL
(	NULL
88	NULL
)	NULL
,	NULL
5'-GATCCGGCTGAC-GTCATCAAGCTA-3	NULL
``	NULL
;	NULL
the	NULL
consensus	NULL
metallothionein	NULL
Ia	NULL
AP-1	NULL
element	NULL
(	NULL
89	NULL
)	NULL
,	NULL
5-GAGCCGCAAGTGACTCAGCGCGGG-3	NULL
'	NULL
;	NULL
and	NULL
the	NULL
consensus	NULL
DRa	NULL
octamer	NULL
(	NULL
40	NULL
)	NULL
,	NULL
5-CTGACCATTAAAATGCAAATCAATTACTCTT-TGG-3	NULL
'	NULL
.	NULL

The	NULL
GATA	NULL
element	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor-a	NULL
enhancer	NULL
(	NULL
41	NULL
)	NULL
,	NULL
5'-GTTAGAGATAGCATCGCCCCA-3	NULL
'	NULL
,	NULL
was	NULL
used	NULL
as	NULL
a	NULL
nonspecific	NULL
com-petitor	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
labeled	NULL
,	NULL
and	NULL
the	NULL
binding	NULL
reactions	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
,	NULL
except	NULL
that	NULL
reactions	NULL
containing	NULL
recombinant	NULL
proteins	NULL
were	NULL
incubated	NULL
in	NULL
buffer	NULL
containing	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
125	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
2	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
5	NULL
mg/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
2	NULL
mM	NULL
phenylmethylsul-fonyl	NULL
fluoride	NULL
,	NULL
and	NULL
2	NULL
pg/ml	NULL
pepstatin	NULL
A	NULL
.	NULL

In	NULL
experiments	NULL
using	NULL
antiserum	NULL
or	NULL
monoclonal	NULL
antibodies	NULL
to	NULL
specific	NULL
transcription	NULL
factors	NULL
,	NULL
these	NULL
were	NULL
routinely	NULL
preincubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
for	NULL
2	NULL
h	NULL
on	NULL
ice	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
probe	NULL
.	NULL

Bound	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
6	NULL
%	NULL
Duracryl	NULL
gels	NULL
(	NULL
Millipore	NULL
Corp.	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
0.4	NULL
X	NULL
Tris	NULL
borate/EDTA	NULL
buffer	NULL
,	NULL
and	NULL
then	NULL
the	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
autoradiographed	NULL
overnight	NULL
.	NULL

DNA	NULL
Binding	NULL
Assays-The	NULL
DNA	NULL
template	NULL
for	NULL
the	NULL
footprinting	NULL
experiment	NULL
was	NULL
made	NULL
by	NULL
end	NULL
labeling	NULL
a	NULL
human	NULL
(	NULL
-850	NULL
to	NULL
+50	NULL
bp	NULL
)	NULL
IFN-y	NULL
promoter	NULL
fragment	NULL
at	NULL
the	NULL
downstream	NULL
end	NULL
.	NULL

The	NULL
binding	NULL
reactions	NULL
and	NULL
DNase	NULL
I	NULL
digestions	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
31966	NULL
A	NULL
a	NULL
O	NULL
w	NULL
3	NULL
.	NULL

Probes	NULL
5	NULL
&	NULL
%	NULL
IFN-y	NULL
E	NULL
P	NULL
o	NULL
6	NULL
a	NULL
o	NULL
Comp	NULL
.	NULL

soG=-O	NULL
<	NULL
zZ	NULL
y	NULL
oct.	NULL
-	NULL
&	NULL
_	NULL
EM	NULL
*	NULL
1	NULL
b	NULL
_	NULL
,	NULL
**	NULL
554+	NULL
wat	NULL
.	NULL
'	NULL

.	NULL

U	NULL
-MT	NULL
s1	NULL
B2	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
91011	NULL
crf	NULL
FoF	NULL
oe	NULL
eee	NULL
Gee	NULL
eerie	NULL
e	NULL
rete	NULL
I	NULL
+P	NULL
U	NULL
1	NULL
+P	NULL
B	NULL
Probe	NULL
Proximal	NULL
IFN-y	NULL
E	NULL
on	NULL
!	NULL

oa	NULL
bk	NULL
50	NULL
$	NULL
~	NULL
aL	NULL
L	NULL
5	NULL
iela	NULL
0	NULL
T	NULL
-o	NULL
ukdus	NULL
ss	NULL
.	NULL

a	NULL
6A	NULL
.	NULL

0	NULL
<	NULL
oa	NULL
£	NULL
a	NULL
A1	NULL
buf	NULL
A2C	NULL
<	NULL
%	NULL
oic	NULL
#	NULL
(	NULL
0	NULL
)	NULL
(	NULL
e	NULL
is	NULL
#	NULL
(	NULL
=	NULL
I1234567891011	NULL
Il	NULL
|	NULL
Uns	NULL
I	NULL
+P	NULL
Jurkat	NULL
extract	NULL
C	NULL
g	NULL
c	NULL
g	NULL
#	NULL
-	NULL
3	NULL
we	NULL
u	NULL
?	NULL

-	NULL
'	NULL
>	NULL
g	NULL
'=	NULL
g	NULL
T	NULL
w	NULL
7	NULL
u	NULL
$	NULL
40	NULL
§40	NULL
§§	NULL
1	NULL
g.	NULL
6	NULL
1	NULL
g.	NULL
6	NULL
1	NULL
A	NULL
0	NULL
.	NULL

g	NULL
6	NULL
*	NULL
®	NULL
-a	NULL
A1	NULL
A2C	NULL
«	NULL
B1C	NULL
wo	NULL
R	NULL
t	NULL
b	NULL
d	NULL
“	NULL
F	NULL
a	NULL
«	NULL
B2	NULL
|	NULL
1	NULL
2	NULL
3	NULL
”	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
1011	NULL
12J	NULL
Uns	NULL
|	NULL
+P	NULL
IFN-y	NULL
AP-1	NULL
probe	NULL
probe	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Identification	NULL
of	NULL
specific	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
family	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
in	NULL
Jurkat	NULL
T	NULL
cell	NULL
nuclear	NULL
extract	NULL
.	NULL

A	NULL
,	NULL
EMSA	NULL
showing	NULL
complexes	NULL
generated	NULL
by	NULL
CRE	NULL
,	NULL
NFIL-2A	NULL
,	NULL
and	NULL
AP-1	NULL
probes	NULL
(	NULL
Zanes	NULL
1-3	NULL
)	NULL
incubated	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
stimulated	NULL
Jurkat	NULL
T	NULL
cell	NULL
nuclear	NULL
extract	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
750	NULL
,	NULL
250	NULL
,	NULL
and	NULL
75	NULL
ng	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
by	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
probe	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
from	NULL
either	NULL
unstimulated	NULL
(	NULL
U	NULL
;	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
stimulated	NULL
(	NULL
Zanes	NULL
5-11	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
375	NULL
ng	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

Specific	NULL
complexes	NULL
generated	NULL
by	NULL
the	NULL
IFN-y	NULL
probe	NULL
are	NULL
labeled	NULL
on	NULL
the	NULL
right	NULL
(	NULL
Oct-1	NULL
indicated	NULL
by	NULL
arrow	NULL
)	NULL
,	NULL
and	NULL
complexes	NULL
(	NULL
Comp	NULL
.	NULL
)	NULL

generated	NULL
by	NULL
the	NULL
consensus	NULL
elements	NULL
are	NULL
designated	NULL
on	NULL
the	NULL
left	NULL
.	NULL

Lanes	NULL
6-11	NULL
demonstrate	NULL
the	NULL
ability	NULL
of	NULL
excess	NULL
(	NULL
10	NULL
ng	NULL
)	NULL
unlabeled	NULL
oligonucleotides	NULL
to	NULL
compete	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
IFN-y	NULL
proximal	NULL
probe	NULL
.	NULL

Competitors	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
lane	NULL
6	NULL
,	NULL
IFN-y	NULL
proximal	NULL
element	NULL
(	NULL
wild	NULL
type	NULL
,	NULL
WT	NULL
)	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
CRE	NULL
;	NULL
lane	NULL
8	NULL
,	NULL
NFIL-2A	NULL
;	NULL
lane	NULL
9	NULL
,	NULL
octamer	NULL
;	NULL
lane	NULL
10	NULL
,	NULL
AP-1	NULL
;	NULL
and	NULL
lane	NULL
11	NULL
,	NULL
a	NULL
nonspecific	NULL
(	NULL
NS	NULL
)	NULL
control	NULL
oligonucleotide	NULL
.	NULL

B	NULL
,	NULL
EMSA	NULL
using	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
probe	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
from	NULL
unstimulated	NULL
(	NULL
Uns	NULL
;	NULL
lanes	NULL
1-4	NULL
)	NULL
and	NULL
stimulated	NULL
(	NULL
Zanes	NULL
5-11	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
150	NULL
ng	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

Antiserum/antibody	NULL
added	NULL
was	NULL
as	NULL
follows	NULL
:	NULL
Zanes	NULL
1	NULL
and	NULL
5	NULL
,	NULL
none	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
9	NULL
,	NULL
polyclonal	NULL
(	NULL
p	NULL
)	NULL
ATF-2	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
10	NULL
,	NULL
monoclonal	NULL
(	NULL
m	NULL
)	NULL
ATF-2	NULL
;	NULL
lanes	NULL
4	NULL
and	NULL
11	NULL
,	NULL
polyclonal	NULL
Jun	NULL
family	NULL
(	NULL
pan-Jun	NULL
)	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
CREB/ATE-1/	NULL
CREM	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
ATF-l-specific	NULL
;	NULL
and	NULL
lane	NULL
8	NULL
,	NULL
CREB-1l-specific	NULL
.	NULL

Specific	NULL
complexes	NULL
are	NULL
labeled	NULL
on	NULL
the	NULL
left	NULL
.	NULL

The	NULL
AZ	NULL
complex	NULL
that	NULL
is	NULL
blocked	NULL
by	NULL
the	NULL
pan-Jun	NULL
antibody	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
arrow	NULL
on	NULL
the	NULL
right	NULL
.	NULL

C	NULL
,	NULL
EMSA	NULL
using	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
probe	NULL
(	NULL
Zanes	NULL
1-9	NULL
)	NULL
and	NULL
the	NULL
AP-1	NULL
probe	NULL
(	NULL
lanes	NULL
10-12	NULL
)	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
from	NULL
unstimulated	NULL
(	NULL
Zanes	NULL
1-3	NULL
)	NULL
and	NULL
stimulated	NULL
(	NULL
lanes	NULL
4-12	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Antiserum	NULL
was	NULL
as	NULL
follows	NULL
:	NULL
lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
7	NULL
,	NULL
and	NULL
10	NULL
,	NULL
none	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
,	NULL
polyclonal	NULL
Jun	NULL
family	NULL
(	NULL
pan-Jun	NULL
)	NULL
;	NULL
Control	NULL
of	NULL
IFN-y	NULL
Expression	NULL
binding	NULL
reactions	NULL
with	NULL
the	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
utilized	NULL
3	NULL
ug	NULL
of	NULL
protein	NULL
.	NULL

RESULTS	NULL
The	NULL
IFN-y	NULL
Proximal	NULL
Element	NULL
Directs	NULL
Activation-specific	NULL
,	NULL
Cyclosporin-sensitive	NULL
Expression	NULL
in	NULL
T	NULL
Cells-Using	NULL
transient	NULL
transfection	NULL
of	NULL
reporter	NULL
constructs	NULL
containing	NULL
10-bp	NULL
scanning	NULL
internal	NULL
deletions	NULL
,	NULL
our	NULL
laboratory	NULL
identified	NULL
two	NULL
highly	NULL
con-served	NULL
,	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
immediate	NULL
5'-flanking	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
IFN-y	NULL
gene	NULL
,	NULL
which	NULL
were	NULL
necessary	NULL
for	NULL
activation-specific	NULL
and	NULL
cyclosporin-sensitive	NULL
expression	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
21	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
most	NULL
proximal	NULL
of	NULL
these	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
,	NULL
like	NULL
the	NULL
intact	NULL
IFN-y	NULL
promoter	NULL
,	NULL
is	NULL
sufficient	NULL
to	NULL
confer	NULL
activation-specific	NULL
and	NULL
cyeclosporin-sensitive	NULL
expression	NULL
,	NULL
two	NULL
tandem	NULL
copies	NULL
of	NULL
this	NULL
element	NULL
were	NULL
placed	NULL
upstream	NULL
of	NULL
the	NULL
basal	NULL
IFN-y	NULL
promoter	NULL
driving	NULL
expression	NULL
of	NULL
a	NULL
B-galactosidase	NULL
reporter	NULL
gene	NULL
and	NULL
transfected	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Expression	NULL
from	NULL
the	NULL
proximal	NULL
dimer	NULL
construct	NULL
was	NULL
stimulated	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
as	NULL
that	NULL
from	NULL
the	NULL
full-length	NULL
promoter	NULL
(	NULL
pIFN-538	NULL
)	NULL
by	NULL
ionomycin	NULL
and	NULL
PMA	NULL
and	NULL
was	NULL
blocked	NULL
by	NULL
cyclosporin	NULL
(	NULL
>	NULL
85	NULL
%	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
expression	NULL
of	NULL
both	NULL
these	NULL
constructs	NULL
was	NULL
minimal	NULL
in	NULL
unstimulated	NULL
cells	NULL
and	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
or	NULL
PMA	NULL
alone	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
dimer	NULL
of	NULL
the	NULL
proximal	NULL
element	NULL
was	NULL
sufficient	NULL
for	NULL
properly	NULL
regulated	NULL
expression	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
robust	NULL
expression	NULL
observed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
expression	NULL
from	NULL
the	NULL
proximal	NULL
dimer	NULL
and	NULL
the	NULL
full-length	NULL
promoter	NULL
constructs	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
from	NULL
a	NULL
promoterless	NULL
construct	NULL
(	NULL
pEQ3	NULL
)	NULL
and	NULL
lower	NULL
than	NULL
that	NULL
from	NULL
the	NULL
basal	NULL
promoter	NULL
construct	NULL
(	NULL
pIFN-39	NULL
)	NULL
in	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
U937	NULL
mono-cyte-macrophages	NULL
or	NULL
L929	NULL
fibroblasts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Very	NULL
low	NULL
levels	NULL
of	NULL
expression	NULL
were	NULL
observed	NULL
in	NULL
the	NULL
816	NULL
B	NULL
cell	NULL
line	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
data	NULL
indicating	NULL
that	NULL
transformed	NULL
B	NULL
cell	NULL
lines	NULL
express	NULL
IFN-y	NULL
in	NULL
low	NULL
amounts	NULL
(	NULL
42	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
like	NULL
the	NULL
full-length	NULL
promoter	NULL
,	NULL
the	NULL
proximal	NULL
dimer	NULL
appears	NULL
sufficient	NULL
to	NULL
confer	NULL
activation-	NULL
and	NULL
cell	NULL
lineage-specific	NULL
expression	NULL
.	NULL

The	NULL
IFN-y	NULL
Proximal	NULL
Element	NULL
Binds	NULL
Members	NULL
of	NULL
the	NULL
CREB/	NULL
ATF	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
Octamer	NULL
Families-The	NULL
proximal	NULL
element	NULL
of	NULL
the	NULL
IFN-y	NULL
promoter	NULL
has	NULL
partial	NULL
homology	NULL
to	NULL
the	NULL
NFIL-2A	NULL
element	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
,	NULL
which	NULL
binds	NULL
octamer	NULL
,	NULL
AP-1	NULL
(	NULL
including	NULL
c-Jun	NULL
,	NULL
JunD	NULL
,	NULL
and	NULL
Fos	NULL
proteins	NULL
)	NULL
,	NULL
and	NULL
NFAT	NULL
proteins	NULL
(	NULL
10	NULL
,	NULL
36	NULL
,	NULL
44-46	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
sites	NULL
of	NULL
AP-1	NULL
and	NULL
CREB/ATF	NULL
transcription	NULL
factors	NULL
are	NULL
closely	NULL
related	NULL
,	NULL
and	NULL
certain	NULL
members	NULL
of	NULL
these	NULL
families	NULL
can	NULL
form	NULL
cross-family	NULL
heterodimers	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
probe	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
probes	NULL
containing	NULL
NFIL-2A	NULL
,	NULL
octamer	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
CRE	NULL
elements	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

In	NULL
previous	NULL
studies	NULL
,	NULL
EMSA	NULL
of	NULL
the	NULL
proximal	NULL
IFN-y	NULL
element	NULL
showed	NULL
two	NULL
intense	NULL
complexes	NULL
,	NULL
A	NULL
and	NULL
B	NULL
(	NULL
21	NULL
)	NULL
,	NULL
which	NULL
are	NULL
now	NULL
resolved	NULL
into	NULL
doublets	NULL
,	NULL
and	NULL
a	NULL
previously	NULL
undetected	NULL
intermediate-mobility	NULL
complex	NULL
.	NULL

Also	NULL
noted	NULL
in	NULL
response	NULL
to	NULL
activation	NULL
,	NULL
the	NULL
A1	NULL
complex	NULL
is	NULL
barely	NULL
detectable	NULL
,	NULL
and	NULL
A2	NULL
is	NULL
the	NULL
predominant	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

This	NULL
difference	NULL
was	NULL
seen	NULL
in	NULL
five	NULL
independently	NULL
prepared	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

When	NULL
used	NULL
as	NULL
unlabeled	NULL
competitors	NULL
in	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
,	NULL
the	NULL
CRE	NULL
oligonucleotide	NULL
markedly	NULL
reduced	NULL
all	NULL
the	NULL
complexes	NULL
generated	NULL
by	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
probe	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
the	NULL
intermediate-mobility	NULL
complex	NULL
.	NULL

The	NULL
NFIL-2A	NULL
competitor	NULL
completely	NULL
blocked	NULL
formation	NULL
of	NULL
the	NULL
intermediate	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
,	NULL
c-Jun-specific	NULL
;	NULL
lanes	NULL
8	NULL
and	NULL
11	NULL
,	NULL
polyclonal	NULL
Fos	NULL
family	NULL
(	NULL
pan-Fos	NULL
)	NULL
;	NULL
and	NULL
lanes	NULL
9	NULL
and	NULL
12	NULL
,	NULL
c-Fos-specific	NULL
.	NULL

The	NULL
asterisk	NULL
indicates	NULL
the	NULL
supershifted	NULL
c-Jun	NULL
complex	NULL
present	NULL
only	NULL
in	NULL
stimulated	NULL
extracts	NULL
.	NULL

The	NULL
black	NULL
arrowhead	NULL
indicates	NULL
the	NULL
supershifted	NULL
c-Fos	NULL
complex	NULL
,	NULL
while	NULL
the	NULL
gray	NULL
arrowhead	NULL
indicates	NULL
the	NULL
pan-Fos	NULL
supershifted	NULL
complex	NULL
.	NULL

I	NULL
+	NULL
P	NULL
,	NULL
ionomycin	NULL
and	NULL
PMA	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Control	NULL
of	NULL
IFN-y	NULL
Expression	NULL
A	NULL
.	NULL

y-	NULL
_-	NULL
y-	NULL
=	NULL
Recombinant	NULL
t	NULL
E	NULL
[	NULL
[	NULL
mat	NULL
Proteins	NULL
4	NULL
4	NULL
4	NULL
4	NULL
m	NULL
~	NULL
O	NULL
aO	NULL
7	NULL
Oe	NULL
O	NULL
t	NULL
O	NULL
a	NULL
O	NULL
T	NULL
O	NULL
EEE	NULL
0	NULL
<	NULL
Go	NULL
40	NULL
4	NULL
O4	NULL
Ga	NULL
G4	NULL
G	NULL
<	NULL
o4	NULL
<	NULL
ATF-	NULL
1	NULL
[	NULL
ATF-	NULL
2	NULL
-t	NULL
ATE-	NULL
1/CRE	NULL
l	NULL
ugh	NULL
CHEBf	NULL
...	NULL
.	NULL

w	NULL
#	NULL
|	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
1	NULL
1	NULL
1	NULL
1	NULL
|	NULL
1	NULL
|	NULL
1	NULL
Probes	NULL
CRE	NULL
IFN-y	NULL
_	NULL
AP-1	NULL
_	NULL
NFIL2A	NULL
B	NULL
Recombinant	NULL
N	NULL
N	NULL
f	NULL
N	NULL
LL	NULL
L	NULL
LL	NULL
.	NULL

LL	NULL
Protei	NULL
-	NULL
Fa	NULL
-	NULL
Fa	NULL
-	NULL
Pa	NULL
-	NULL
®	NULL
oteins	NULL
<	NULL
IN-2	NULL
GENE	NULL
qNE	NULL
“	NULL
Tm-E	NULL
t	NULL
wot	NULL
t	NULL
ic	NULL
+	NULL
4	NULL
w	NULL
#	NULL
t	NULL
u	NULL
t	NULL
s	NULL
5G	NULL
g	NULL
{	NULL
hG	NULL
s	NULL
£s	NULL
s	NULL
EE	NULL
B	NULL
RLE	NULL
PACE	NULL
AB	NULL
C	NULL
S	NULL
mien	NULL
thom	NULL
«	NULL
#	NULL
@	NULL
-	NULL
@	NULL
jun	NULL
»	NULL
jun/ATF-	NULL
2-3	NULL
»	NULL
ATF-2	NULL
34	NULL
>	NULL
jun/fosm-	NULL
‘	NULL
.	NULL

1	NULL
2	NULL
8	NULL
40	NULL
506	NULL
7	NULL
8	NULL
gdo111213141516	NULL
CRE	NULL
IFN-y	NULL
_	NULL
AP-1	NULL
-	NULL
NFIL2A	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

IFN-y	NULL
proximal	NULL
element	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
recombinant	NULL
ATF-1	NULL
,	NULL
CREB	NULL
,	NULL
Jun	NULL
,	NULL
and	NULL
Jun/ATF-2	NULL
heterodimers	NULL
.	NULL

A	NULL
,	NULL
EMSA	NULL
using	NULL
CRE	NULL
(	NULL
Zanes	NULL
1-4	NULL
)	NULL
,	NULL
the	NULL
proximal	NULL
IFN-y	NULL
element	NULL
(	NULL
Zanes	NULL
5-8	NULL
)	NULL
,	NULL
AP-1	NULL
(	NULL
lanes	NULL
9-12	NULL
)	NULL
,	NULL
and	NULL
NFIL-2A	NULL
(	NULL
Zanes	NULL
13-16	NULL
)	NULL
as	NULL
probes	NULL
with	NULL
recombinant	NULL
proteins	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
25	NULL
ng	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

For	NULL
each	NULL
probe	NULL
,	NULL
a	NULL
10	NULL
nM	NULL
concentration	NULL
of	NULL
the	NULL
indicated	NULL
recombinant	NULL
protein	NULL
was	NULL
added	NULL
:	NULL
CREB	NULL
(	NULL
amino	NULL
acids	NULL
254-827	NULL
)	NULL
,	NULL
ATF-1	NULL
(	NULL
full-length	NULL
)	NULL
,	NULL
CREB	NULL
plus	NULL
ATF-1	NULL
,	NULL
or	NULL
ATF-2	NULL
(	NULL
amino	NULL
acids	NULL
350-505	NULL
)	NULL
.	NULL

B	NULL
,	NULL
EMSA	NULL
using	NULL
the	NULL
same	NULL
probes	NULL
with	NULL
recombinant	NULL
c-Jun	NULL
(	NULL
amino	NULL
acids	NULL
199-334	NULL
)	NULL
,	NULL
c-Jun	NULL
plus	NULL
ATF-2	NULL
,	NULL
ATF-2	NULL
,	NULL
or	NULL
c-Jun	NULL
plus	NULL
c-Fos	NULL
(	NULL
amino	NULL
acids	NULL
189-200	NULL
)	NULL
.	NULL

For	NULL
each	NULL
probe	NULL
,	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
were	NULL
added	NULL
at	NULL
100	NULL
nM	NULL
and	NULL
ATF-2	NULL
at	NULL
10	NULL
nM	NULL
.	NULL

Note	NULL
that	NULL
since	NULL
the	NULL
recombinant	NULL
proteins	NULL
used	NULL
were	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
ATF-1	NULL
,	NULL
the	NULL
DNA-binding	NULL
domains	NULL
rather	NULL
than	NULL
the	NULL
full-length	NULL
proteins	NULL
,	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
complexes	NULL
in	NULL
these	NULL
EMSAs	NULL
can	NULL
not	NULL
be	NULL
compared	NULL
directly	NULL
with	NULL
that	NULL
of	NULL
the	NULL
proteins	NULL
present	NULL
in	NULL
Jurkat	NULL
T	NULL
cell	NULL
extracts	NULL
shown	NULL
in	NULL
the	NULL
other	NULL
figures	NULL
.	NULL

Probes	NULL
mobility	NULL
complex	NULL
and	NULL
inhibited	NULL
formation	NULL
of	NULL
the	NULL
other	NULL
complexes	NULL
.	NULL

The	NULL
AP-1	NULL
oligonucleotide	NULL
partially	NULL
competed	NULL
for	NULL
the	NULL
A2	NULL
and	NULL
B	NULL
complexes	NULL
,	NULL
but	NULL
much	NULL
less	NULL
than	NULL
seen	NULL
with	NULL
CRE	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
the	NULL
presence	NULL
of	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
proteins	NULL
in	NULL
complexes	NULL
formed	NULL
with	NULL
the	NULL
proximal	NULL
element	NULL
.	NULL

To	NULL
confirm	NULL
this	NULL
and	NULL
to	NULL
identify	NULL
the	NULL
specific	NULL
factors	NULL
contained	NULL
within	NULL
each	NULL
complex	NULL
,	NULL
antisera	NULL
specific	NULL
for	NULL
the	NULL
various	NULL
factors	NULL
were	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reactions	NULL
.	NULL

Antibodies	NULL
to	NULL
CREB/	NULL
ATF-1	NULL
proteins	NULL
supershifted	NULL
or	NULL
attenuated	NULL
the	NULL
B1-B2	NULL
complexes	NULL
,	NULL
suggesting	NULL
the	NULL
presence	NULL
of	NULL
ATF-1	NULL
,	NULL
CREB	NULL
,	NULL
and	NULL
perhaps	NULL
other	NULL
members	NULL
of	NULL
the	NULL
CREB/ATF-1	NULL
family	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
6-8	NULL
)	NULL
.	NULL

The	NULL
results	NULL
were	NULL
similar	NULL
with	NULL
extracts	NULL
from	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Antibody	NULL
to	NULL
ATF-2	NULL
blocked	NULL
or	NULL
supershifted	NULL
the	NULL
A1	NULL
and	NULL
A2	NULL
complexes	NULL
in	NULL
unstimulated	NULL
cells	NULL
31967	NULL
F	NULL
a	NULL
``	NULL
&	NULL
&	NULL
Yow	NULL
434	NULL
ba	NULL
PEE	NULL
BE	NULL
&	NULL
®	NULL
sa	NULL
``	NULL
&	NULL
&	NULL
iF	NULL
rlly	NULL
_	NULL
8	NULL
¢	NULL
$	NULL
54	NULL
3	NULL
ca	NULL
witte	NULL
lvn	NULL
:	NULL
wt	NULL
P	NULL
wom	NULL
wae	NULL
fala	NULL
)	NULL
waren	NULL
*	NULL
hans	NULL
lie	NULL
e	NULL
~*	NULL
mame	NULL
sourse	NULL
i	NULL
P	NULL
s	NULL
2.-	NULL
;	NULL
W	NULL
‘	NULL
mmm	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
43	NULL
MMe	NULL
40	NULL
MPA	NULL
AAA	NULL
AAA	NULL
CTT	NULL
GTG	NULL
AAA	NULL
ATA	NULL
CGT	NULL
AAT	NULL
CCT	NULL
CAG	NULL
GAG	NULL
A	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

DNase	NULL
I	NULL
footprint	NULL
analysis	NULL
of	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
.	NULL

Recombinant	NULL
NFAT	NULL
,	NULL
AP-1	NULL
(	NULL
c-Jun	NULL
and	NULL
Fra-1	NULL
)	NULL
,	NULL
and	NULL
ATF-2	NULL
proteins	NULL
or	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
tested	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
IFN-y	NULL
promoter	NULL
.	NULL

The	NULL
region	NULL
corresponding	NULL
to	NULL
the	NULL
proximal	NULL
element	NULL
(	NULL
from	NULL
-40	NULL
to	NULL
-78	NULL
bp	NULL
)	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
lane	NULL
labeled	NULL
GA	NULL
is	NULL
a	NULL
Maxam-Gilbert	NULL
sequencing	NULL
reaction	NULL
showing	NULL
the	NULL
purine	NULL
sequence	NULL
of	NULL
the	NULL
labeled	NULL
complementary	NULL
strand	NULL
.	NULL

A	NULL
schematic	NULL
depicting	NULL
the	NULL
regions	NULL
protected	NULL
by	NULL
AP-1	NULL
and	NULL
ATF-2	NULL
(	NULL
boxed	NULL
)	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
central	NULL
ACGT	NULL
sequence	NULL
in	NULL
the	NULL
region	NULL
of	NULL
CRE	NULL
homology	NULL
is	NULL
underlined	NULL
for	NULL
reference	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
but	NULL
only	NULL
partially	NULL
blocked	NULL
or	NULL
supershifted	NULL
the	NULL
more	NULL
prominent	NULL
A2	NULL
complex	NULL
in	NULL
stimulated	NULL
cells	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
,	NULL
complex	NULL
indicated	NULL
by	NULL
arrow	NULL
)	NULL
.	NULL

Antibodies	NULL
to	NULL
ATF-3	NULL
and	NULL
ATF-4	NULL
had	NULL
no	NULL
consistent	NULL
effects	NULL
upon	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
complexes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

An	NULL
antiserum	NULL
recognizing	NULL
all	NULL
Jun	NULL
proteins	NULL
completely	NULL
blocked	NULL
the	NULL
A2	NULL
complex	NULL
in	NULL
both	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
11	NULL
)	NULL
,	NULL
and	NULL
a	NULL
c-Jun-specific	NULL
antiserum	NULL
produced	NULL
a	NULL
supershifted	NULL
complex	NULL
in	NULL
stimulated	NULL
Jurkat	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
antibodies	NULL
to	NULL
the	NULL
Fos	NULL
family	NULL
of	NULL
proteins	NULL
or	NULL
to	NULL
c-Fos	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
complexes	NULL
formed	NULL
with	NULL
the	NULL
proximal	NULL
element	NULL
probe	NULL
,	NULL
although	NULL
each	NULL
antibody	NULL
blocked	NULL
and/or	NULL
supershifted	NULL
complexes	NULL
formed	NULL
with	NULL
an	NULL
AP-1	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lanes	NULL
7-12	NULL
)	NULL
.	NULL

Several	NULL
observations	NULL
suggest	NULL
that	NULL
the	NULL
intermediate	NULL
complex	NULL
is	NULL
generated	NULL
by	NULL
binding	NULL
of	NULL
Oct-1	NULL
to	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

1	NULL
)	NULL
The	NULL
intermediate-mobility	NULL
complex	NULL
comigrated	NULL
with	NULL
the	NULL
predominant	NULL
complex	NULL
generated	NULL
by	NULL
the	NULL
NFIL-2A	NULL
probe	NULL
.	NULL

2	NULL
)	NULL
This	NULL
complex	NULL
was	NULL
inhibited	NULL
by	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
,	NULL
NFIL-2A	NULL
,	NULL
and	NULL
consensus	NULL
octamer	NULL
oligonucleotides	NULL
,	NULL
but	NULL
not	NULL
by	NULL
CRE-	NULL
or	NULL
AP-1l-containing	NULL
oligonucleotides	NULL
.	NULL

3	NULL
)	NULL
Oct-1-specific	NULL
antiserum	NULL
blocked	NULL
formation	NULL
of	NULL
this	NULL
complex	NULL
and	NULL
the	NULL
corresponding	NULL
NFIL-2A	NULL
complex	NULL
,	NULL
but	NULL
had	NULL
little	NULL
or	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
A	NULL
or	NULL
B	NULL
complexes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Results	NULL
obtained	NULL
with	NULL
recombinant	NULL
transcription	NULL
factors	NULL
supported	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
Jurkat	NULL
T	NULL
cell	NULL
extracts	NULL
.	NULL

The	NULL
IFN-y	NULL
proximal	NULL
element	NULL
probe	NULL
readily	NULL
bound	NULL
recombinant	NULL
CREB	NULL
,	NULL
CREB/ATEF-1	NULL
,	NULL
and	NULL
ATF-2	NULL
,	NULL
whereas	NULL
ATF-1	NULL
bound	NULL
poorly	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
lanes	NULL
5-8	NULL
)	NULL
.	NULL

The	NULL
AP-1	NULL
and	NULL
NFIL-2A	NULL
oligonucleotides	NULL
bound	NULL
these	NULL
proteins	NULL
less	NULL
well	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
lanes	NULL
9-16	NULL
)	NULL
.	NULL

c-Jun	NULL
homodimers	NULL
and	NULL
c-Jun/c-Fos	NULL
heterodimers	NULL
formed	NULL
complexes	NULL
with	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
,	NULL
although	NULL
the	NULL
complexes	NULL
generated	NULL
were	NULL
less	NULL
intense	NULL
than	NULL
those	NULL
bound	NULL
by	NULL
either	NULL
the	NULL
consensus	NULL
CRE	NULL
or	NULL
AP-1	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

When	NULL
c-Jun	NULL
and	NULL
ATF-2	NULL
were	NULL
added	NULL
together	NULL
in	NULL
the	NULL
ratio	NULL
yielding	NULL
optimal	NULL
binding	NULL
(	NULL
10	NULL
:	NULL
1	NULL
)	NULL
,	NULL
essentially	NULL
all	NULL
complexes	NULL
ran	NULL
with	NULL
a	NULL
mobility	NULL
intermediate	NULL
between	NULL
those	NULL
seen	NULL
with	NULL
either	NULL
protein	NULL
alone	NULL
,	NULL
suggesting	NULL
that	NULL
c-Jun/ATF-2	NULL
heterodimers	NULL
were	NULL
preferred	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

The	NULL
consensus	NULL
CRE	NULL
probe	NULL
also	NULL
bound	NULL
c-Jun/ATF-2	NULL
heterodimers	NULL
well	NULL
,	NULL
although	NULL
the	NULL
intermediate	NULL
heterodimer	NULL
complex	NULL
is	NULL
ob-secured	NULL
by	NULL
a	NULL
predominance	NULL
of	NULL
c-Jun	NULL
homodimer	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
31968	NULL
A	NULL
71	NULL
AP-1	NULL
c===-=	NULL
--	NULL
--	NULL
43	NULL
ATF-2	NULL
WT	NULL
A	NULL
AAA	NULL
CTT	NULL
GTG	NULL
AAA	NULL
ATA	NULL
CGT	NULL
AAT	NULL
CCT	NULL
CAG	NULL
G	NULL
M1	NULL
CGC	NULL
M2	NULL
GCG	NULL
M3	NULL
TC	NULL
TM	NULL
A	NULL
GT-	NULL
M5	NULL
A	NULL
AAA	NULL
CTT	NULL
GTG	NULL
AAA	NULL
ATA	NULL
TGT	NULL
AAT	NULL
CCT	NULL
CAG	NULL
B	NULL
Probes	NULL
WT	NULL
Mi	NULL
M2	NULL
M3	NULL
M4	NULL
MS	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
78	NULL
9	NULL
101112	NULL
A1	NULL
wip	NULL
v4	NULL
A2	NULL
-m	NULL
ar	NULL
inn	NULL
“	NULL
ime	NULL
bab	NULL
»	NULL
¥	NULL
U	NULL
S	NULL
U	NULL
s||U	NULL
S|	NULL
ju	NULL
S	NULL
u	NULL
s	NULL
[	NULL
JU	NULL
S	NULL
Jurkat	NULL
T	NULL
cell	NULL
nuclear	NULL
extract	NULL
C	NULL
Competitors	NULL
E	NULL
5	NULL
8	NULL
8	NULL
f	NULL
2	NULL
2	NULL
1	NULL
2	NULL
3	NULL
4	NULL
506	NULL
7	NULL
8	NULL
9	NULL
ATF-1	NULL
[	NULL
ATF-1	NULL
JCREB	NULL
aes	NULL
Cit	NULL
-	NULL
&	NULL
-	NULL
W	NULL
@	NULL
W	NULL
5	NULL
nM	NULL
CREB	NULL
_	NULL
2.5	NULL
nM	NULL
CREB	NULL
+2.5	NULL
nM	NULL
ATF-	NULL
1	NULL
Competitors	NULL
E	NULL
5	NULL
8	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
,	NULL
a	NULL
¥	NULL
#	NULL
#	NULL
L1	NULL
ATF-2	NULL
100	NULL
nM	NULL
Jun	NULL
+10	NULL
nM	NULL
ATF-2	NULL
~	NULL
M4	NULL
u	NULL
pS	NULL
8	NULL
w	NULL
NS	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
bases	NULL
critical	NULL
for	NULL
binding	NULL
of	NULL
transcription	NULL
factors	NULL
to	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
.	NULL

A	NULL
,	NULL
the	NULL
sequences	NULL
of	NULL
the	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
IFN-y	NULL
proximal	NULL
element	NULL
and	NULL
oligonucleotides	NULL
MI1-M5	NULL
with	NULL
mutations	NULL
in	NULL
this	NULL
region	NULL
.	NULL

The	NULL
central	NULL
ACGT	NULL
sequence	NULL
is	NULL
underlined	NULL
,	NULL
and	NULL
the	NULL
regions	NULL
footprinted	NULL
by	NULL
AP-1	NULL
and	NULL
ATF-2	NULL
are	NULL
indi-cated	NULL
.	NULL

B	NULL
,	NULL
EMSA	NULL
using	NULL
wild-type	NULL
or	NULL
mutated	NULL
oligonucleotides	NULL
as	NULL
probes	NULL
binding	NULL
3	NULL
pg	NULL
of	NULL
unstimulated	NULL
(	NULL
U	NULL
)	NULL
or	NULL
stimulated	NULL
(	NULL
S	NULL
)	NULL
Jurkat	NULL
nuclear	NULL
extract	NULL
with	NULL
200	NULL
ng	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

Complexes	NULL
are	NULL
noted	NULL
on	NULL
the	NULL
left	NULL
,	NULL
with	NULL
Oct-1	NULL
indicated	NULL
by	NULL
the	NULL
small	NULL
arrow	NULL
.	NULL

The	NULL
large	NULL
arrowhead	NULL
denotes	NULL
a	NULL
novel	NULL
rapidly	NULL
migrating	NULL
complex	NULL
that	NULL
falls	NULL
midway	NULL
between	NULL
the	NULL
usual	NULL
complexes	NULL
and	NULL
unbound	NULL
probe	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

C	NULL
,	NULL
EMSA	NULL
demonstrating	NULL
the	NULL
ability	NULL
of	NULL
25	NULL
ng	NULL
of	NULL
the	NULL
indicated	NULL
oligonucleotide	NULL
to	NULL
compete	NULL
for	NULL
recombinant	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
wild-type	NULL
IFN-y	NULL
probe	NULL
with	NULL
50	NULL
ng	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

The	NULL
reactions	NULL
contained	NULL
5	NULL
nM	NULL
CREB	NULL
(	NULL
amino	NULL
acids	NULL
254-827	NULL
)	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
Control	NULL
of	NULL
IFN-y	NULL
Expression	NULL
In	NULL
contrast	NULL
,	NULL
the	NULL
AP-1	NULL
and	NULL
NFIL-2A	NULL
probes	NULL
bound	NULL
ATF-2	NULL
and	NULL
c-Jun/ATF-2	NULL
heterodimers	NULL
poorly	NULL
or	NULL
not	NULL
at	NULL
all	NULL
compared	NULL
with	NULL
c-Jun	NULL
or	NULL
c-Jun/c-Fos	NULL
.	NULL

To	NULL
better	NULL
define	NULL
the	NULL
regions	NULL
of	NULL
interaction	NULL
of	NULL
these	NULL
proteins	NULL
with	NULL
the	NULL
proximal	NULL
element	NULL
,	NULL
DNase	NULL
I	NULL
footprint	NULL
analysis	NULL
was	NULL
performed	NULL
.	NULL

Recombinant	NULL
ATF-2	NULL
protected	NULL
a	NULL
large	NULL
region	NULL
of	NULL
the	NULL
proximal	NULL
element	NULL
spanning	NULL
from	NULL
-63	NULL
to	NULL
-43	NULL
bp	NULL
,	NULL
whereas	NULL
AP-1	NULL
(	NULL
recombinant	NULL
c-Jun	NULL
and	NULL
Fra-1	NULL
)	NULL
protected	NULL
an	NULL
overlapping	NULL
but	NULL
smaller	NULL
region	NULL
(	NULL
-63	NULL
to	NULL
-53	NULL
bp	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

NFATp	NULL
,	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
conjunction	NULL
with	NULL
AP-1	NULL
or	NULL
ATF-2	NULL
,	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
this	NULL
region	NULL
.	NULL

The	NULL
region	NULL
protected	NULL
by	NULL
recombinant	NULL
ATF-2	NULL
corresponded	NULL
to	NULL
that	NULL
protected	NULL
by	NULL
the	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
.	NULL

No	NULL
differences	NULL
were	NULL
seen	NULL
in	NULL
the	NULL
footprints	NULL
generated	NULL
with	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
nuclear	NULL
extracts	NULL
or	NULL
when	NULL
AP-1	NULL
and	NULL
ATF-2	NULL
were	NULL
added	NULL
together	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
binds	NULL
CREB	NULL
,	NULL
ATF-1	NULL
,	NULL
ATF-2	NULL
,	NULL
and	NULL
c-Jun	NULL
under	NULL
conditions	NULL
similar	NULL
to	NULL
those	NULL
required	NULL
by	NULL
elements	NULL
containing	NULL
these	NULL
consensus	NULL
motifs	NULL
.	NULL

CREB/ATF-1	NULL
and	NULL
c-Jun/ATF-2	NULL
bind	NULL
readily	NULL
as	NULL
heterodimers	NULL
.	NULL

Upon	NULL
stimulation	NULL
,	NULL
c-Jun	NULL
is	NULL
induced	NULL
and	NULL
binds	NULL
as	NULL
a	NULL
homodimer	NULL
or	NULL
preferentially	NULL
as	NULL
a	NULL
heterodimer	NULL
with	NULL
ATF-2	NULL
.	NULL

Although	NULL
not	NULL
observed	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
Jun/Fos	NULL
heterodimers	NULL
in	NULL
low	NULL
abundance	NULL
can	NULL
not	NULL
be	NULL
excluded	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
NFIL-2A	NULL
element	NULL
,	NULL
NFATp	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
this	NULL
site	NULL
.	NULL

Mutations	NULL
within	NULL
the	NULL
Proximal	NULL
Element	NULL
Identify	NULL
Bases	NULL
Critical	NULL
for	NULL
Binding	NULL
and	NULL
Markedly	NULL
Reduce	NULL
Reporter	NULL
Gene	NULL
Expres-ston-The	NULL
central	NULL
ACGT	NULL
sequence	NULL
of	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
is	NULL
highly	NULL
conserved	NULL
(	NULL
21	NULL
)	NULL
,	NULL
lies	NULL
within	NULL
the	NULL
sequence	NULL
with	NULL
the	NULL
best	NULL
homology	NULL
to	NULL
a	NULL
consensus	NULL
CRE	NULL
motif	NULL
,	NULL
and	NULL
is	NULL
within	NULL
the	NULL
region	NULL
protected	NULL
by	NULL
ATF-2	NULL
and	NULL
AP-1	NULL
in	NULL
the	NULL
footprint	NULL
analysis	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
,	NULL
these	NULL
were	NULL
identified	NULL
as	NULL
the	NULL
most	NULL
critical	NULL
bases	NULL
for	NULL
binding	NULL
in	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

A	NULL
probe	NULL
containing	NULL
the	NULL
M3	NULL
mutation	NULL
,	NULL
which	NULL
disrupts	NULL
this	NULL
sequence	NULL
,	NULL
failed	NULL
to	NULL
bind	NULL
any	NULL
of	NULL
the	NULL
specific	NULL
complexes	NULL
usually	NULL
seen	NULL
with	NULL
the	NULL
wild-type	NULL
probe	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
a	NULL
more	NULL
rapidly	NULL
migrating	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
7-8	NULL
)	NULL
.	NULL

The	NULL
M5	NULL
mutation	NULL
,	NULL
which	NULL
consists	NULL
of	NULL
a	NULL
single	NULL
base	NULL
change	NULL
from	NULL
C	NULL
to	NULL
T	NULL
within	NULL
the	NULL
CRE	NULL
motif	NULL
,	NULL
bound	NULL
only	NULL
the	NULL
Oct-1	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
.	NULL

The	NULL
retention	NULL
of	NULL
Oct-1	NULL
binding	NULL
may	NULL
be	NULL
due	NULL
to	NULL
reconstitution	NULL
of	NULL
the	NULL
sequence	NULL
AATAT-GTAA	NULL
found	NULL
in	NULL
the	NULL
NFIL-2A	NULL
element	NULL
,	NULL
which	NULL
overlaps	NULL
the	NULL
putative	NULL
octamer	NULL
motif	NULL
(	NULL
36	NULL
)	NULL
,	NULL
and	NULL
was	NULL
confirmed	NULL
using	NULL
Oct-1	NULL
antisera	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
oligonucleotides	NULL
with	NULL
the	NULL
M1	NULL
,	NULL
M2	NULL
,	NULL
and	NULL
M4	NULL
mutations	NULL
had	NULL
minimal	NULL
effects	NULL
.	NULL

The	NULL
M1	NULL
and	NULL
M4	NULL
mutations	NULL
produced	NULL
complexes	NULL
that	NULL
were	NULL
identical	NULL
to	NULL
the	NULL
wild-type	NULL
probe	NULL
.	NULL

Although	NULL
the	NULL
M1	NULL
mutation	NULL
appears	NULL
to	NULL
bind	NULL
complexes	NULL
more	NULL
intensely	NULL
,	NULL
this	NULL
was	NULL
not	NULL
a	NULL
consistent	NULL
finding	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
seen	NULL
with	NULL
the	NULL
M2	NULL
mutation	NULL
,	NULL
except	NULL
it	NULL
did	NULL
not	NULL
form	NULL
the	NULL
Oct-1	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
bases	NULL
in	NULL
the	NULL
center	NULL
of	NULL
the	NULL
CRE	NULL
homology	NULL
were	NULL
also	NULL
critical	NULL
for	NULL
binding	NULL
of	NULL
recombinant	NULL
proteins	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
the	NULL
results	NULL
with	NULL
heterodimers	NULL
of	NULL
CREB/ATF-1	NULL
and	NULL
Jun/ATF-2	NULL
are	NULL
shown	NULL
.	NULL

Results	NULL
with	NULL
the	NULL
individual	NULL
recombinant	NULL
factors	NULL
were	NULL
similar	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

When	NULL
used	NULL
as	NULL
competitors	NULL
,	NULL
the	NULL
M1	NULL
,	NULL
M2	NULL
,	NULL
and	NULL
M4	NULL
oligonucleotides	NULL
competed	NULL
nearly	NULL
as	NULL
well	NULL
as	NULL
the	NULL
wild	NULL
type	NULL
,	NULL
but	NULL
the	NULL
M3	NULL
and	NULL
M5	NULL
mutations	NULL
failed	NULL
to	NULL
alter	NULL
binding	NULL
of	NULL
complexes	NULL
to	NULL
the	NULL
wild-type	NULL
IFN-y	NULL
element	NULL
to	NULL
any	NULL
appreciable	NULL
extent	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
these	NULL
mutations	NULL
on	NULL
expression	NULL
were	NULL
tested	NULL
by	NULL
transient	NULL
transfection	NULL
of	NULL
reporter	NULL
constructs	NULL
containing	NULL
head-to-tail	NULL
dimers	NULL
of	NULL
the	NULL
proximal	NULL
element	NULL
with	NULL
the	NULL
M1-M4	NULL
mutations	NULL
or	NULL
with	NULL
the	NULL
full-length	NULL
IFN-y	NULL
promoter	NULL
(	NULL
pIFN-538	NULL
)	NULL
containing	NULL
the	NULL
C	NULL
to	NULL
T	NULL
mutation	NULL
(	NULL
M5	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
or	NULL
2.5	NULL
nM	NULL
CREB	NULL
plus	NULL
2.5	NULL
nM	NULL
ATF-1	NULL
(	NULL
Zanes	NULL
2-9	NULL
)	NULL
in	NULL
the	NULL
upper	NULL
panel	NULL
and	NULL
10	NULL
nM	NULL
ATF-2	NULL
(	NULL
amino	NULL
acids	NULL
850-505	NULL
)	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
10	NULL
nM	NULL
ATF-2	NULL
plus	NULL
100	NULL
nM	NULL
c-Jun	NULL
(	NULL
amino	NULL
acids	NULL
199-834	NULL
)	NULL
(	NULL
Zanes	NULL
2-9	NULL
)	NULL
in	NULL
the	NULL
lower	NULL
panel	NULL
.	NULL

Complexes	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
.	NULL

The	NULL
Jun/ATF-2	NULL
heterodimer	NULL
complex	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Control	NULL
of	NULL
IFN-y	NULL
Expression	NULL
expression	NULL
from	NULL
the	NULL
M3	NULL
and	NULL
MS	NULL
reporter	NULL
constructs	NULL
,	NULL
in	NULL
which	NULL
the	NULL
mutations	NULL
disrupted	NULL
the	NULL
central	NULL
ACGT	NULL
sequence	NULL
,	NULL
was	NULL
reduced	NULL
to	NULL
the	NULL
low	NULL
level	NULL
of	NULL
the	NULL
basal	NULL
promoter	NULL
(	NULL
pIFN-39	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
reporter	NULL
constructs	NULL
with	NULL
the	NULL
M1	NULL
and	NULL
M2	NULL
muta-tions	NULL
,	NULL
which	NULL
minimally	NULL
affected	NULL
binding	NULL
by	NULL
EMSA	NULL
but	NULL
which	NULL
are	NULL
within	NULL
the	NULL
region	NULL
footprinted	NULL
both	NULL
by	NULL
ATF-2	NULL
and	NULL
by	NULL
AP-1	NULL
,	NULL
showed	NULL
markedly	NULL
decreased	NULL
expression	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
reporter	NULL
construct	NULL
with	NULL
the	NULL
M4	NULL
mutation	NULL
,	NULL
which	NULL
is	NULL
located	NULL
at	NULL
the	NULL
3'-end	NULL
of	NULL
the	NULL
proximal	NULL
element	NULL
in	NULL
a	NULL
region	NULL
footprinted	NULL
only	NULL
by	NULL
ATF-2	NULL
,	NULL
was	NULL
expressed	NULL
at	NULL
levels	NULL
comparable	NULL
to	NULL
those	NULL
of	NULL
the	NULL
wild-type	NULL
proximal	NULL
element	NULL
dimer	NULL
and	NULL
the	NULL
full-length	NULL
IFN-y	NULL
promoter	NULL
(	NULL
pIFN-538	NULL
)	NULL
.	NULL

Role	NULL
of	NULL
Jun	NULL
,	NULL
ATF-2	NULL
,	NULL
and	NULL
CREB	NULL
in	NULL
Regulation	NULL
of	NULL
Expression	NULL
via	NULL
the	NULL
IFN-y	NULL
Proximal	NULL
Element-The	NULL
data	NULL
described	NULL
above	NULL
suggested	NULL
that	NULL
members	NULL
of	NULL
the	NULL
CREB/ATF-1	NULL
,	NULL
ATF-2	NULL
,	NULL
and	NULL
Jun	NULL
families	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
function	NULL
of	NULL
the	NULL
proximal	NULL
element	NULL
.	NULL

To	NULL
assess	NULL
this	NULL
,	NULL
wild-type	NULL
and	NULL
dominant-negative	NULL
mutated	NULL
genes	NULL
were	NULL
tested	NULL
in	NULL
cotransfection	NULL
assays	NULL
.	NULL

Wild-type	NULL
CREB	NULL
,	NULL
which	NULL
as	NULL
a	NULL
homodimer	NULL
or	NULL
heterodimer	NULL
with	NULL
ATF-1	NULL
was	NULL
the	NULL
most	NULL
abundant	NULL
complex	NULL
observed	NULL
by	NULL
EMSA	NULL
,	NULL
had	NULL
an	NULL
inhibitory	NULL
effect	NULL
on	NULL
expression	NULL
from	NULL
the	NULL
proximal	NULL
dimer	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
;	NULL
a	NULL
similar	NULL
trend	NULL
,	NULL
although	NULL
not	NULL
statistically	NULL
significant	NULL
,	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
full-length	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

These	NULL
effects	NULL
were	NULL
not	NULL
observed	NULL
with	NULL
the	NULL
DNA-binding	NULL
mutant	NULL
KCREB	NULL
.	NULL

The	NULL
DNA-binding	NULL
mutant	NULL
of	NULL
c-Jun	NULL
(	NULL
c-JunABR	NULL
)	NULL
consistently	NULL
and	NULL
markedly	NULL
inhibited	NULL
expression	NULL
from	NULL
both	NULL
the	NULL
full-length	NULL
promoter	NULL
and	NULL
proximal	NULL
dimer	NULL
constructs	NULL
even	NULL
at	NULL
low	NULL
concentrations	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

Wild-type	NULL
c-Jun	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
the	NULL
proximal	NULL
dimer	NULL
,	NULL
but	NULL
at	NULL
higher	NULL
concentrations	NULL
inhibited	NULL
the	NULL
full-length	NULL
promoter	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
results	NULL
with	NULL
cotransfection	NULL
of	NULL
CREB	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
their	NULL
mutants	NULL
,	NULL
cotransfection	NULL
of	NULL
wild-type	NULL
human	NULL
ATF-2	NULL
or	NULL
of	NULL
a	NULL
dominant-negative	NULL
ATF-2	NULL
mutant	NULL
containing	NULL
only	NULL
the	NULL
DNA-binding	NULL
domain	NULL
(	NULL
ATF-2BR	NULL
)	NULL
did	NULL
not	NULL
consistently	NULL
affect	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
E	NULL
and	NULL
F	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
cotransfection	NULL
of	NULL
murine	NULL
ATF-2	NULL
(	NULL
CRE-BP2.1	NULL
)	NULL
or	NULL
of	NULL
a	NULL
mutant	NULL
containing	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
DNA-binding	NULL
domain	NULL
(	NULL
CRE-BP	NULL
1mu	NULL
)	NULL
had	NULL
little	NULL
effect	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
CREB	NULL
and	NULL
c-Jun	NULL
have	NULL
opposing	NULL
effects	NULL
on	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
and	NULL
promoter	NULL
,	NULL
whereas	NULL
a	NULL
role	NULL
for	NULL
ATF-2	NULL
was	NULL
not	NULL
demonstrated	NULL
by	NULL
these	NULL
cotransfection	NULL
experiments	NULL
.	NULL

Methylation	NULL
of	NULL
the	NULL
CpG	NULL
Dinucleotide	NULL
Impedes	NULL
Binding	NULL
of	NULL
Factors	NULL
to	NULL
the	NULL
IFN-y	NULL
Proximal	NULL
Element-Previous	NULL
studies	NULL
indicated	NULL
that	NULL
the	NULL
degree	NULL
of	NULL
methylation	NULL
of	NULL
the	NULL
CpG	NULL
dinucleotide	NULL
within	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
correlates	NULL
inversely	NULL
with	NULL
the	NULL
capacity	NULL
of	NULL
T	NULL
cell	NULL
populations	NULL
or	NULL
T	NULL
cell	NULL
clones	NULL
to	NULL
produce	NULL
this	NULL
lymphokine	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

In	NULL
CD4*	NULL
Thl	NULL
clones	NULL
,	NULL
this	NULL
CpG	NULL
is	NULL
fully	NULL
demethylated	NULL
,	NULL
whereas	NULL
in	NULL
Th2	NULL
clones	NULL
,	NULL
it	NULL
is	NULL
fully	NULL
methylated	NULL
;	NULL
this	NULL
difference	NULL
is	NULL
selective	NULL
in	NULL
that	NULL
there	NULL
is	NULL
not	NULL
a	NULL
general	NULL
hypo-methylation	NULL
of	NULL
all	NULL
CpG	NULL
dinucleotides	NULL
in	NULL
the	NULL
IFN-y	NULL
gene	NULL
in	NULL
Th1	NULL
as	NULL
compared	NULL
with	NULL
Th2	NULL
T	NULL
cell	NULL
clones	NULL
(	NULL
22	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
effect	NULL
of	NULL
methylation	NULL
on	NULL
binding	NULL
of	NULL
transcription	NULL
factors	NULL
to	NULL
this	NULL
element	NULL
,	NULL
EMSA	NULL
was	NULL
performed	NULL
with	NULL
oligonucleotide	NULL
probes	NULL
containing	NULL
5-methyleytosine	NULL
in	NULL
the	NULL
CpG	NULL
of	NULL
each	NULL
strand	NULL
.	NULL

Compared	NULL
with	NULL
non-methylated	NULL
IFN-y	NULL
proximal	NULL
element	NULL
and	NULL
CRE	NULL
probes	NULL
,	NULL
the	NULL
characteristic	NULL
complexes	NULL
formed	NULL
with	NULL
stimulated	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
were	NULL
markedly	NULL
reduced	NULL
when	NULL
methylated	NULL
probes	NULL
were	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
novel	NULL
faster	NULL
migrating	NULL
complexes	NULL
were	NULL
observed	NULL
with	NULL
the	NULL
methylated	NULL
IFN-y	NULL
proximal	NULL
element	NULL
probe	NULL
.	NULL

The	NULL
lower	NULL
apparent	NULL
binding	NULL
affinity	NULL
of	NULL
the	NULL
methylated	NULL
oligonucleotides	NULL
for	NULL
CREB	NULL
,	NULL
ATF-2	NULL
,	NULL
and	NULL
Jun	NULL
proteins	NULL
present	NULL
in	NULL
nuclear	NULL
extracts	NULL
was	NULL
confirmed	NULL
using	NULL
non-methylated	NULL
probes	NULL
and	NULL
methylated	NULL
oligonucleotides	NULL
as	NULL
unlabeled	NULL
competitors	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
,	NULL
a	NULL
methylated	NULL
IFN-y	NULL
proximal	NULL
element	NULL
oligonucleotide	NULL
competed	NULL
much	NULL
less	NULL
effectively	NULL
than	NULL
the	NULL
non-methylated	NULL
31969	NULL
A	NULL
0.035	NULL
0.030	NULL
|	NULL
0.025	NULL
L.	NULL
i-	NULL
<	NULL
.	NULL

0.020	NULL
|	NULL
m	NULL
&	NULL
oo15	NULL
.	NULL

0	NULL
0.010	NULL
0.005	NULL
|	NULL
0.000	NULL
|_-=	NULL
.	NULL

pel	NULL
3	NULL
®	NULL
G	NULL
<	NULL
Bo	NULL
t	NULL
<	NULL
g	NULL
3	NULL
§	NULL
£30	NULL
S	NULL
§	NULL
f	NULL
o	NULL
LL	NULL
Z	NULL
a	NULL
E	NULL
a	NULL
-	NULL
&	NULL
-	NULL
$	NULL
9	NULL
2	NULL
&	NULL
0.035	NULL
0.030	NULL
.	NULL

0.025	NULL
<	NULL
0020	NULL
0	NULL
€	NULL
cols	NULL
6	NULL
0.010	NULL
0.005	NULL
0.000	NULL
MS	NULL
pa	NULL
O	NULL
L	NULL
a.	NULL
piFn-39	NULL
|	NULL
pIFN-538	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Transient	NULL
transfection	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
confirms	NULL
that	NULL
mutations	NULL
that	NULL
alter	NULL
binding	NULL
are	NULL
critical	NULL
for	NULL
activation-induced	NULL
expression	NULL
.	NULL

A	NULL
,	NULL
B-galactosidase	NULL
expression	NULL
observed	NULL
with	NULL
the	NULL
promoterless	NULL
pEQ3	NULL
construct	NULL
,	NULL
the	NULL
basal	NULL
(	NULL
pIFN-89	NULL
)	NULL
and	NULL
full-length	NULL
(	NULL
pIFN-538	NULL
)	NULL
IFN-y	NULL
promoter	NULL
constructs	NULL
,	NULL
and	NULL
constructs	NULL
containing	NULL
dimers	NULL
of	NULL
the	NULL
wild-type	NULL
or	NULL
mutated	NULL
M1-M4	NULL
sequences	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
means	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
two	NULL
experiments	NULL
.	NULL

B	NULL
,	NULL
B-galactosidase	NULL
expression	NULL
observed	NULL
with	NULL
the	NULL
full-length	NULL
IFN-y	NULL
promoter	NULL
containing	NULL
the	NULL
wild	NULL
type	NULL
(	NULL
pIFN-538	NULL
)	NULL
or	NULL
M5	NULL
(	NULL
C	NULL
to	NULL
T	NULL
)	NULL
mutation	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
means	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
three	NULL
experiments	NULL
.	NULL

+P	NULL
,	NULL
ionomycin	NULL
and	NULL
PMA	NULL
;	NULL
uns	NULL
,	NULL
unstimulated	NULL
;	NULL
CPR	NULL
,	NULL
chlorophenol	NULL
red	NULL
production	NULL
.	NULL

oligonucleotide	NULL
for	NULL
binding	NULL
of	NULL
recombinant	NULL
CREB	NULL
,	NULL
ATF-2	NULL
,	NULL
and	NULL
c-Jun	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
methylation	NULL
on	NULL
competition	NULL
for	NULL
binding	NULL
of	NULL
CREB	NULL
was	NULL
generally	NULL
more	NULL
pronounced	NULL
than	NULL
on	NULL
competition	NULL
for	NULL
binding	NULL
of	NULL
ATF-2	NULL
and	NULL
c-Jun	NULL
;	NULL
this	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
studies	NULL
that	NULL
showed	NULL
that	NULL
binding	NULL
of	NULL
CREB	NULL
and	NULL
ATF-1	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
V	NULL
;	NULL
decamer	NULL
element	NULL
is	NULL
more	NULL
sensitive	NULL
to	NULL
methylation	NULL
of	NULL
the	NULL
CpG	NULL
dinucleotide	NULL
than	NULL
binding	NULL
of	NULL
ATF-2	NULL
(	NULL
48	NULL
)	NULL
.	NULL

DISCUSSION	NULL
The	NULL
current	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
proximal	NULL
element	NULL
of	NULL
the	NULL
IFN-y	NULL
promoter	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
gene	NULL
regulation	NULL
and	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
differential	NULL
expression	NULL
of	NULL
this	NULL
lymphokine	NULL
.	NULL

As	NULL
shown	NULL
,	NULL
the	NULL
proximal	NULL
element	NULL
contains	NULL
sufficient	NULL
information	NULL
to	NULL
mimic	NULL
with	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
fidelity	NULL
the	NULL
properties	NULL
of	NULL
the	NULL
endogenous	NULL
gene	NULL
and	NULL
of	NULL
the	NULL
full-length	NULL
promoter	NULL
with	NULL
respect	NULL
to	NULL
activation	NULL
requirements	NULL
and	NULL
cell	NULL
lineage-specific	NULL
expression	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
transiently	NULL
transfected	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
dimer	NULL
directs	NULL
activation-specific	NULL
expression	NULL
,	NULL
which	NULL
is	NULL
30-fold	NULL
greater	NULL
than	NULL
that	NULL
of	NULL
the	NULL
basal	NULL
promoter	NULL
(	NULL
pIFN-39	NULL
)	NULL
,	NULL
``	NULL
and	NULL
T	NULL
cells	NULL
from	NULL
trans-genic	NULL
mice	NULL
in	NULL
which	NULL
a	NULL
dimer	NULL
of	NULL
this	NULL
element	NULL
directs	NULL
expression	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
produce	NULL
luciferase	NULL
in	NULL
an	NULL
activa-	NULL
2	NULL
L.	NULL
A.	NULL
Penix	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
31970	NULL
A	NULL
0.040	NULL
Control	NULL
of	NULL
IFN-y	NULL
Expression	NULL
0.025	NULL
0.086	NULL
J	NULL
+P	NULL
[	NULL
{	NULL
m	NULL
uns	NULL
0.025	NULL
}	NULL
.	NULL

0.030	NULL
0.020	NULL
CFRICAT	NULL
O1	NULL
J	NULL
.	NULL

010	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Cotransfection	NULL
of	NULL
expression	NULL
vectors	NULL
containing	NULL
wild-type	NULL
or	NULL
dom-	NULL
inant-negative	NULL
CREB	NULL
,	NULL
c-Jun	NULL
,	NULL
or	NULL
©000	NULL
|	NULL
«	NULL
za	NULL
ATF-2	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
full-length	NULL
IFN-y	NULL
promoter	NULL
(	NULL
pIFN-538	NULL
)	NULL
or	NULL
proximal	NULL
dimer	NULL
reporter	NULL
constructs	NULL
and	NULL
graded	NULL
amounts	NULL
of	NULL
the	NULL
in	NULL
dicated	NULL
transcription	NULL
factor	NULL
expression	NULL
C	NULL
plasmid	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
RSV	NULL
pro	NULL
0.005	NULL
peas	NULL
pIFN-39	NULL
CREB	NULL
KCREB	NULL
pFi.ses	NULL
0.020	NULL
.	NULL

0.015	NULL
CPRICAT	NULL
0.010	NULL
J	NULL
.	NULL

0.000	NULL
|_	NULL
i	NULL
_-eoggnes	NULL
Proximal	NULL
Dimer	NULL
peQs	NULL
pIFN-39	NULL
moter	NULL
;	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
RSV	NULL
vector	NULL
aces	NULL
was	NULL
kept	NULL
constant	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
con-	NULL
acso	NULL
trol	NULL
pReRSV	NULL
plasmid	NULL
lacking	NULL
a	NULL
cDNA	NULL
in	NULL
sert	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
means	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
0025	NULL
|	NULL
three	NULL
to	NULL
four	NULL
experiments	NULL
for	NULL
CREB	NULL
(	NULL
4	NULL
and	NULL
B	NULL
)	NULL
,	NULL
two	NULL
to	NULL
three	NULL
experiments	NULL
for	NULL
c-Jun	NULL
(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
,	NULL
and	NULL
two	NULL
experiments	NULL
for	NULL
ATF-2	NULL
(	NULL
E	NULL
and	NULL
F	NULL
)	NULL
.	NULL

At	NULL
all	NULL
concentrations	NULL
tested	NULL
,	NULL
nono	NULL
.	NULL

CREB	NULL
significantly	NULL
inhibited	NULL
transcription	NULL
from	NULL
the	NULL
proximal	NULL
dimer	NULL
construct	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
by	NULL
two-tailed	NULL
Student	NULL
's	NULL
¢	NULL
test	NULL
)	NULL
;	NULL
onto	NULL
|	NULL
asa	NULL
c-JunABR	NULL
significantly	NULL
inhibited	NULL
tran	NULL
CPRICAT	NULL
Ll	NULL
3	NULL
5	NULL
&	NULL
€	NULL
a	NULL
6k	NULL
o	NULL
pEQS	NULL
pIFN-39	NULL
Proximal	NULL
Dimer	NULL
aot2	NULL
scription	NULL
from	NULL
the	NULL
proximal	NULL
dimer	NULL
and	NULL
8	NULL
i	NULL
full-length	NULL
promoter	NULL
constructs	NULL
(	NULL
p	NULL
<	NULL
0.01	NULL
*~	NULL
&	NULL
and	NULL
p	NULL
<	NULL
0.02	NULL
,	NULL
respectively	NULL
)	NULL
;	NULL
and	NULL
c-Jun	NULL
sig-	NULL
nificantly	NULL
inhibited	NULL
expression	NULL
from	NULL
the	NULL
full-length	NULL
promoter	NULL
construct	NULL
(	NULL
p	NULL
<	NULL
0.02	NULL
)	NULL
.	NULL

E	NULL
KCREB	NULL
,	NULL
ATF-2	NULL
,	NULL
and	NULL
ATF-2BR	NULL
did	NULL
not	NULL
omo	NULL
significantly	NULL
affect	NULL
expression	NULL
.	NULL

I+P	NULL
,	NULL
iono-	NULL
ons	NULL
mycin	NULL
and	NULL
PMA	NULL
;	NULL
uns	NULL
,	NULL
unstimulated	NULL
;	NULL
CPR	NULL
,	NULL
noso	NULL
chlorophenol	NULL
red	NULL
production	NULL
.	NULL

0025	NULL
0020	NULL
CPRICAT	NULL
0015	NULL
0010	NULL
0006	NULL
.	NULL

peas	NULL
pIFN-29	NULL
tion-specific	NULL
,	NULL
cyclosporin-sensitive	NULL
manner	NULL
.	NULL
``	NULL

The	NULL
IFN-y	NULL
proximal	NULL
element	NULL
displayed	NULL
a	NULL
complex	NULL
binding	NULL
pattern	NULL
,	NULL
engaging	NULL
Oct-1	NULL
,	NULL
CREB/ATF-1	NULL
,	NULL
ATF-2	NULL
,	NULL
and	NULL
Jun	NULL
proteins	NULL
,	NULL
while	NULL
lacking	NULL
a	NULL
consensus	NULL
element	NULL
for	NULL
any	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
members	NULL
of	NULL
the	NULL
CREB/ATF	NULL
and	NULL
AP-1	NULL
families	NULL
display	NULL
binding	NULL
affinities	NULL
that	NULL
vary	NULL
with	NULL
dimer	NULL
composition	NULL
and	NULL
that	NULL
depend	NULL
on	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
(	NULL
47	NULL
,	NULL
49	NULL
,	NULL
50	NULL
)	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
the	NULL
proximal	NULL
element	NULL
more	NULL
closely	NULL
resembles	NULL
a	NULL
CRE-like	NULL
site	NULL
and	NULL
displayed	NULL
a	NULL
pattern	NULL
of	NULL
binding	NULL
similar	NULL
to	NULL
,	NULL
but	NULL
distinct	NULL
from	NULL
,	NULL
that	NULL
of	NULL
the	NULL
CRE	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NFIL-2A	NULL
elements	NULL
.	NULL

The	NULL
results	NULL
obtained	NULL
by	NULL
EMSA	NULL
also	NULL
are	NULL
supported	NULL
by	NULL
preliminary	NULL
fluorescence	NULL
anisotropy	NULL
data	NULL
(	NULL
51	NULL
)	NULL
:	NULL
ATF-2	NULL
bound	NULL
to	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
with	NULL
higher	NULL
affinity	NULL
than	NULL
did	NULL
CREB	NULL
or	NULL
GST/c-Jun	NULL
and	NULL
bound	NULL
this	NULL
element	NULL
with	NULL
an	NULL
affinity	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
a	NULL
consensus	NULL
CRE	NULL
,	NULL
while	NULL
CREB	NULL
and	NULL
GST/c-Jun	NULL
bound	NULL
the	NULL
consensus	NULL
CRE	NULL
with	NULL
greater	NULL
affinity	NULL
than	NULL
the	NULL
proximal	NULL
element	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
multiple	NULL
factors	NULL
bind	NULL
to	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
,	NULL
but	NULL
binding	NULL
by	NULL
ATF-2-containing	NULL
complexes	NULL
may	NULL
be	NULL
favored	NULL
.	NULL

Jun	NULL
or	NULL
Jun/ATF-2	NULL
Facilitate	NULL
IFN-y	NULL
Promoter-mediated	NULL
Transcription-The	NULL
simplest	NULL
interpretation	NULL
of	NULL
the	NULL
EMSA	NULL
,	NULL
foot	NULL
°	NULL
T.	NULL
Aune	NULL
,	NULL
L.	NULL
A.	NULL
Penix	NULL
,	NULL
M.	NULL
Rincon	NULL
,	NULL
and	NULL
R.	NULL
Flavell	NULL
,	NULL
submitted	NULL
for	NULL
publication	NULL
.	NULL

0010	NULL
J	NULL
0008	NULL
CPRICAT	NULL
0.004	NULL
0.002	NULL
0.OD	NULL
0	NULL
1	NULL
25	NULL
5	NULL
1	NULL
25	NULL
06	NULL
ATF-2	NULL
ATF-2ER	NULL
Proximal	NULL
Dimer	NULL
a	NULL
ATF2	NULL
ATF-2BR	NULL
§	NULL
piFN.S38	NULL
9	NULL
pIFN-s9	NULL
printing	NULL
,	NULL
and	NULL
cotransfection	NULL
experiments	NULL
is	NULL
that	NULL
activation-de-pendent	NULL
transcription	NULL
through	NULL
the	NULL
IFN-y	NULL
promoter	NULL
and	NULL
its	NULL
proximal	NULL
element	NULL
follows	NULL
in	NULL
part	NULL
from	NULL
the	NULL
induction	NULL
of	NULL
c-Jun	NULL
expression	NULL
and	NULL
binding	NULL
of	NULL
c-Jun	NULL
to	NULL
this	NULL
element	NULL
either	NULL
as	NULL
a	NULL
homodimer	NULL
or	NULL
a	NULL
heterodimer	NULL
with	NULL
ATF-2	NULL
or	NULL
other	NULL
Jun	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

T	NULL
cell	NULL
activation	NULL
results	NULL
in	NULL
the	NULL
calcineurin-dependent	NULL
activation	NULL
of	NULL
c-Jun	NULL
amino-terminal/stress-activated	NULL
protein	NULL
kinases	NULL
,	NULL
which	NULL
phosphorylate	NULL
c-Jun	NULL
and	NULL
ATF-2	NULL
(	NULL
14	NULL
,	NULL
52	NULL
)	NULL
,	NULL
and	NULL
would	NULL
allow	NULL
these	NULL
proteins	NULL
to	NULL
participate	NULL
in	NULL
transcription	NULL
ini-tiation	NULL
.	NULL

Supporting	NULL
this	NULL
interpretation	NULL
is	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
the	NULL
c-Jun	NULL
DNA-binding	NULL
domain	NULL
mutant	NULL
,	NULL
which	NULL
blocked	NULL
transcription	NULL
from	NULL
the	NULL
full-length	NULL
IFN-y	NULL
promoter	NULL
and	NULL
the	NULL
proximal	NULL
element	NULL
dimer	NULL
.	NULL

At	NULL
high	NULL
concentrations	NULL
,	NULL
Jun	NULL
partially	NULL
inhibited	NULL
expression	NULL
from	NULL
the	NULL
full-length	NULL
promoter	NULL
,	NULL
suggesting	NULL
that	NULL
c-Jun	NULL
,	NULL
or	NULL
transcription	NULL
factors	NULL
with	NULL
which	NULL
it	NULL
interacts	NULL
,	NULL
may	NULL
act	NULL
on	NULL
regions	NULL
within	NULL
the	NULL
IFN-y	NULL
promoter	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
proximal	NULL
element	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
an	NULL
inhibitory	NULL
effect	NULL
of	NULL
full-length	NULL
c-Jun	NULL
on	NULL
the	NULL
proximal	NULL
element	NULL
may	NULL
reflect	NULL
its	NULL
ability	NULL
to	NULL
function	NULL
in	NULL
this	NULL
context	NULL
as	NULL
a	NULL
homodimer	NULL
,	NULL
whereas	NULL
it	NULL
may	NULL
interact	NULL
more	NULL
efficiently	NULL
as	NULL
a	NULL
heterodimer	NULL
at	NULL
other	NULL
regions	NULL
in	NULL
the	NULL
IFN-y	NULL
promoter	NULL
.	NULL

Preliminary	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
distal	NULL
element	NULL
of	NULL
this	NULL
promoter	NULL
is	NULL
one	NULL
such	NULL
region	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Additional	NULL
evidence	NULL
supporting	NULL
a	NULL
role	NULL
for	NULL
Jun	NULL
or	NULL
Jun	NULL
heterodimers	NULL
comes	NULL
from	NULL
a	NULL
recent	NULL
report	NULL
by	NULL
Young	NULL
and	NULL
co-workers	NULL
(	NULL
53	NULL
)	NULL
,	NULL
who	NULL
found	NULL
that	NULL
cotransfection	NULL
of	NULL
c-Jun	NULL
plasmids	NULL
containing	NULL
activation	NULL
do	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Control	NULL
of	NULL
IFN-y	NULL
Expression	NULL
A	NULL
Probes	NULL
meth	NULL
IFN	NULL
meth	NULL
CRE	NULL
IFN	NULL
CRE	NULL
AM	NULL
Az	NULL
C	NULL
ct	NULL
w	NULL
*	NULL
bo	NULL
IFN-y	NULL
__	NULL
meth	NULL
IFN-y	NULL
_-	NULL
]	NULL
.	NULL

“	NULL
0	NULL
(	NULL
13325	NULL
cu-	NULL
``	NULL
)	NULL
\	NULL
_	NULL
10	NULL
nM	NULL
ATF-2	NULL
_-	NULL
]	NULL
100	NULL
nM	NULL
Jun	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Methylation	NULL
of	NULL
the	NULL
central	NULL
CpG	NULL
dinucleotide	NULL
within	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
alters	NULL
binding	NULL
with	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
and	NULL
recombinant	NULL
factors	NULL
.	NULL

A	NULL
,	NULL
EMSA	NULL
using	NULL
non-methylated	NULL
IFN-y	NULL
proximal	NULL
element	NULL
and	NULL
CRE	NULL
probes	NULL
or	NULL
identical	NULL
oligonucleotides	NULL
synthesized	NULL
with	NULL
a	NULL
5-methyleytosine	NULL
in	NULL
the	NULL
CpG	NULL
dinucleotide	NULL
of	NULL
each	NULL
strand	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
stimulated	NULL
Jurkat	NULL
nuclear	NULL
extract	NULL
.	NULL

The	NULL
novel	NULL
rapidly	NULL
migrating	NULL
complexes	NULL
bound	NULL
only	NULL
by	NULL
the	NULL
methylated	NULL
proximal	NULL
element	NULL
probe	NULL
are	NULL
indicated	NULL
by	NULL
asterisks	NULL
.	NULL

B	NULL
,	NULL
EMSA	NULL
with	NULL
the	NULL
non-methylated	NULL
IFN-y	NULL
proximal	NULL
element	NULL
probe	NULL
binding	NULL
the	NULL
indicated	NULL
recombinant	NULL
proteins	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0	NULL
,	NULL
1	NULL
,	NULL
5	NULL
,	NULL
25	NULL
,	NULL
or	NULL
50	NULL
ng	NULL
of	NULL
non-methylated	NULL
or	NULL
methylated	NULL
(	NULL
meth	NULL
)	NULL
competitor	NULL
oligonucleotide	NULL
.	NULL

main	NULL
mutations	NULL
inhibited	NULL
IFN-y	NULL
promoter	NULL
function	NULL
,	NULL
although	NULL
the	NULL
locus	NULL
of	NULL
the	NULL
inhibitory	NULL
effect	NULL
was	NULL
not	NULL
defined	NULL
.	NULL

The	NULL
current	NULL
studies	NULL
indicate	NULL
that	NULL
c-Jun	NULL
contributes	NULL
to	NULL
activation	NULL
through	NULL
the	NULL
proximal	NULL
element	NULL
of	NULL
the	NULL
IFN-y	NULL
promoter	NULL
,	NULL
but	NULL
do	NULL
not	NULL
exclude	NULL
a	NULL
role	NULL
for	NULL
other	NULL
Jun	NULL
proteins	NULL
in	NULL
this	NULL
process	NULL
.	NULL

Functional	NULL
overlap	NULL
among	NULL
different	NULL
Jun	NULL
family	NULL
proteins	NULL
has	NULL
been	NULL
suggested	NULL
in	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
promoters	NULL
(	NULL
9	NULL
,	NULL
15	NULL
,	NULL
16	NULL
,	NULL
54	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
results	NULL
observed	NULL
with	NULL
c-Jun	NULL
constructs	NULL
,	NULL
no	NULL
consistent	NULL
effect	NULL
on	NULL
transcription	NULL
was	NULL
observed	NULL
when	NULL
murine	NULL
or	NULL
human	NULL
wild-type	NULL
ATF-2	NULL
or	NULL
two	NULL
different	NULL
types	NULL
of	NULL
dominant-negative	NULL
ATF-2	NULL
were	NULL
cotransfected	NULL
along	NULL
with	NULL
the	NULL
IFN-y	NULL
promoter	NULL
or	NULL
proximal	NULL
element	NULL
constructs	NULL
.	NULL

Similarly	NULL
,	NULL
no	NULL
effect	NULL
of	NULL
ATF-2	NULL
was	NULL
observed	NULL
when	NULL
it	NULL
was	NULL
cotransfected	NULL
in	NULL
combination	NULL
with	NULL
c-Jun	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
was	NULL
not	NULL
anticipated	NULL
from	NULL
the	NULL
EMSA	NULL
studies	NULL
,	NULL
which	NULL
suggested	NULL
that	NULL
Jun/ATF-2	NULL
heterodimers	NULL
would	NULL
bind	NULL
preferentially	NULL
over	NULL
other	NULL
Jun-containing	NULL
complexes	NULL
in	NULL
stimulated	NULL
extracts	NULL
.	NULL

However	NULL
,	NULL
this	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
results	NULL
of	NULL
the	NULL
footprinting	NULL
and	NULL
transfection	NULL
experiments	NULL
,	NULL
which	NULL
demonstrated	NULL
that	NULL
mutations	NULL
within	NULL
the	NULL
region	NULL
footprinted	NULL
jointly	NULL
by	NULL
AP-1	NULL
and	NULL
ATF-2	NULL
inhibited	NULL
expression	NULL
;	NULL
by	NULL
contrast	NULL
,	NULL
31971	NULL
Unstim	NULL
Stim	NULL
IFN-y	NULL
Proximal	NULL
Element	NULL
7	NULL
Fic	NULL
.	NULL

9	NULL
.	NULL

Schematic	NULL
representation	NULL
of	NULL
factors	NULL
interacting	NULL
with	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
.	NULL

The	NULL
proximal	NULL
element	NULL
exhibits	NULL
an	NULL
identical	NULL
DNase	NULL
footprint	NULL
in	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
EMSA	NULL
and	NULL
transfection	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
proteins	NULL
contributing	NULL
to	NULL
the	NULL
footprints	NULL
and	NULL
to	NULL
transcription	NULL
mediated	NULL
by	NULL
this	NULL
element	NULL
are	NULL
altered	NULL
by	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

In	NULL
unstimulated	NULL
(	NULL
Unstim	NULL
)	NULL
T	NULL
cells	NULL
,	NULL
CREB	NULL
,	NULL
ATF-1	NULL
,	NULL
ATF-2	NULL
,	NULL
and	NULL
Jun	NULL
family	NULL
proteins	NULL
other	NULL
than	NULL
c-Jun	NULL
are	NULL
present	NULL
,	NULL
whereas	NULL
in	NULL
stimulated	NULL
(	NULL
Stim	NULL
)	NULL
T	NULL
cells	NULL
,	NULL
c-Jun	NULL
or	NULL
c-Jun/ATF-2	NULL
dimers	NULL
are	NULL
present	NULL
.	NULL

c-Jun	NULL
and	NULL
c-Jun/ATF-2	NULL
are	NULL
thought	NULL
to	NULL
be	NULL
phosphorylated	NULL
by	NULL
c-Jun	NULL
amino-terminal/stress-activated	NULL
protein	NULL
kinases	NULL
when	NULL
T	NULL
cells	NULL
are	NULL
activated	NULL
.	NULL

The	NULL
center	NULL
of	NULL
this	NULL
element	NULL
contains	NULL
a	NULL
CpG	NULL
dinucleotide	NULL
,	NULL
the	NULL
methylation	NULL
of	NULL
which	NULL
impedes	NULL
transcription	NULL
factor	NULL
binding	NULL
and	NULL
is	NULL
observed	NULL
in	NULL
types	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
e.g	NULL
.	NULL

Th2	NULL
T	NULL
cells	NULL
)	NULL
that	NULL
do	NULL
not	NULL
transcribe	NULL
IFN-y	NULL
.	NULL

the	NULL
M4	NULL
mutation	NULL
,	NULL
which	NULL
is	NULL
within	NULL
the	NULL
region	NULL
footprinted	NULL
by	NULL
ATF-2	NULL
but	NULL
not	NULL
by	NULL
AP-1	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

These	NULL
results	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
Jun-containing	NULL
dimers	NULL
are	NULL
necessary	NULL
for	NULL
transcriptional	NULL
activation	NULL
,	NULL
but	NULL
the	NULL
other	NULL
constituent	NULL
of	NULL
Jun-containing	NULL
dimers	NULL
may	NULL
not	NULL
be	NULL
critical	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
ATF-2	NULL
is	NULL
not	NULL
limiting	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
or	NULL
that	NULL
the	NULL
effects	NULL
observed	NULL
in	NULL
cotransfection	NULL
assays	NULL
were	NULL
in	NULL
part	NULL
indirect	NULL
since	NULL
ATF-2	NULL
and	NULL
c-Jun	NULL
(	NULL
and	NULL
CREB	NULL
)	NULL
also	NULL
play	NULL
a	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
expression	NULL
of	NULL
AP-1	NULL
proteins	NULL
(	NULL
55	NULL
)	NULL
.	NULL

In	NULL
support	NULL
of	NULL
our	NULL
data	NULL
showing	NULL
the	NULL
lack	NULL
of	NULL
an	NULL
essential	NULL
role	NULL
of	NULL
ATF-2	NULL
in	NULL
IFN-y	NULL
expression	NULL
,	NULL
mice	NULL
in	NULL
which	NULL
the	NULL
ATF-2	NULL
gene	NULL
has	NULL
been	NULL
inactivated	NULL
by	NULL
homologous	NULL
recombination	NULL
do	NULL
not	NULL
differ	NULL
from	NULL
wild-type	NULL
mice	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
IFN-y	NULL
mRNA	NULL
in	NULL
response	NULL
to	NULL
anti-CD3	NULL
antibodies	NULL
.	NULL

*	NULL
Cotransfection	NULL
of	NULL
CREB	NULL
reduced	NULL
transcription	NULL
mediated	NULL
by	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
and	NULL
,	NULL
to	NULL
a	NULL
limited	NULL
extent	NULL
,	NULL
transcription	NULL
from	NULL
the	NULL
full-length	NULL
promoter	NULL
,	NULL
whereas	NULL
the	NULL
DNA-binding	NULL
mutant	NULL
KCREB	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
CREB	NULL
and/or	NULL
other	NULL
factors	NULL
with	NULL
which	NULL
it	NULL
forms	NULL
heterodimers	NULL
may	NULL
have	NULL
a	NULL
net	NULL
inhibitory	NULL
effect	NULL
on	NULL
activation-induced	NULL
IFN-y	NULL
proximal	NULL
element	NULL
function	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

This	NULL
inhibitory	NULL
effect	NULL
probably	NULL
reflects	NULL
competition	NULL
between	NULL
CREB/ATF-1	NULL
and	NULL
Jun	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
.	NULL

Since	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
in	NULL
T	NULL
cells	NULL
may	NULL
enhance	NULL
its	NULL
binding	NULL
to	NULL
DNA	NULL
(	NULL
56	NULL
)	NULL
,	NULL
elevation	NULL
of	NULL
cAMP	NULL
could	NULL
contribute	NULL
to	NULL
this	NULL
dampening	NULL
effect	NULL
;	NULL
this	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
agents	NULL
that	NULL
elevate	NULL
intracellular	NULL
cAMP	NULL
inhibit	NULL
IFN-y	NULL
production	NULL
(	NULL
57	NULL
)	NULL
.	NULL

Interest-ingly	NULL
,	NULL
IL-4	NULL
transcription	NULL
is	NULL
not	NULL
impeded	NULL
by	NULL
cAMP	NULL
(	NULL
58	NULL
,	NULL
59	NULL
)	NULL
,	NULL
and	NULL
differences	NULL
in	NULL
sensitivity	NULL
to	NULL
or	NULL
content	NULL
of	NULL
cAMP	NULL
have	NULL
been	NULL
proposed	NULL
to	NULL
contribute	NULL
to	NULL
differential	NULL
lymphokine	NULL
production	NULL
or	NULL
proliferation	NULL
by	NULL
Thl	NULL
and	NULL
Th2	NULL
CD4*	NULL
T	NULL
cells	NULL
(	NULL
60	NULL
)	NULL
.	NULL

Potential	NULL
Role	NULL
of	NULL
the	NULL
Proximal	NULL
Element	NULL
in	NULL
Selective	NULL
IFN-y	NULL
Expression-In	NULL
addition	NULL
to	NULL
the	NULL
potential	NULL
interactions	NULL
of	NULL
both	NULL
positively	NULL
and	NULL
negatively	NULL
acting	NULL
transcription	NULL
factors	NULL
at	NULL
this	NULL
site	NULL
,	NULL
a	NULL
CpG	NULL
dinucleotide	NULL
within	NULL
the	NULL
proximal	NULL
element	NULL
of	NULL
the	NULL
IFN-y	NULL
promoter	NULL
serves	NULL
as	NULL
a	NULL
target	NULL
for	NULL
methylation	NULL
.	NULL

Since	NULL
methylation	NULL
impeded	NULL
binding	NULL
of	NULL
Jun	NULL
or	NULL
Jun/ATF-2	NULL
proteins	NULL
to	NULL
this	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
,	NULL
methylation	NULL
may	NULL
raise	NULL
the	NULL
effective	NULL
threshold	NULL
concentrations	NULL
of	NULL
phosphorylated	NULL
Jun	NULL
or	NULL
Jun/ATF-2	NULL
needed	NULL
to	NULL
activate	NULL
transcription	NULL
above	NULL
that	NULL
generally	NULL
present	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
in	NULL
situ	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
,	NULL
methylation	NULL
of	NULL
the	NULL
IFN-y	NULL
*L.	NULL
H.	NULL
Glimcher	NULL
,	NULL
personal	NULL
communication	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
31972	NULL
proximal	NULL
element	NULL
correlates	NULL
strongly	NULL
and	NULL
inversely	NULL
with	NULL
the	NULL
capacity	NULL
of	NULL
primary	NULL
T	NULL
cell	NULL
populations	NULL
and	NULL
T	NULL
cell	NULL
clones	NULL
to	NULL
produce	NULL
IFN-y	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
impairing	NULL
the	NULL
binding	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
methylation	NULL
of	NULL
DNA	NULL
at	NULL
CpG	NULL
dinucleotides	NULL
may	NULL
impair	NULL
promoter	NULL
function	NULL
by	NULL
other	NULL
mechanisms	NULL
.	NULL

Methylated	NULL
CpG	NULL
engages	NULL
specific	NULL
proteins	NULL
(	NULL
61	NULL
,	NULL
62	NULL
)	NULL
that	NULL
may	NULL
block	NULL
access	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
and	NULL
may	NULL
alter	NULL
overall	NULL
chromatin	NULL
structure	NULL
(	NULL
63	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
CpG-con-taining	NULL
proximal	NULL
element	NULL
may	NULL
provide	NULL
a	NULL
locus	NULL
at	NULL
which	NULL
cells	NULL
can	NULL
markedly	NULL
limit	NULL
,	NULL
if	NULL
not	NULL
block	NULL
,	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
endogenous	NULL
IFN-y	NULL
gene	NULL
to	NULL
be	NULL
transcribed	NULL
.	NULL

In	NULL
sum	NULL
,	NULL
the	NULL
current	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
IFN-y	NULL
proximal	NULL
element	NULL
,	NULL
like	NULL
the	NULL
IFN-y	NULL
promoter	NULL
,	NULL
is	NULL
selectively	NULL
active	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
selectivity	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
reflect	NULL
the	NULL
binding	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
are	NULL
unique	NULL
to	NULL
cells	NULL
that	NULL
express	NULL
this	NULL
lymphokine	NULL
.	NULL

Rather	NULL
,	NULL
the	NULL
IFN-y	NULL
promoter	NULL
contains	NULL
within	NULL
its	NULL
proximal	NULL
element	NULL
the	NULL
potential	NULL
to	NULL
engage	NULL
proteins	NULL
that	NULL
mediate	NULL
transcription	NULL
(	NULL
c-Jun	NULL
or	NULL
c-Jun/ATF-2	NULL
dimers	NULL
)	NULL
or	NULL
that	NULL
repress	NULL
transcription	NULL
either	NULL
through	NULL
the	NULL
competitive	NULL
binding	NULL
of	NULL
transcription	NULL
factors	NULL
having	NULL
minimal	NULL
agonistic	NULL
activity	NULL
(	NULL
CREB/	NULL
ATF-1	NULL
)	NULL
or	NULL
through	NULL
methylation	NULL
of	NULL
the	NULL
central	NULL
CpG	NULL
dinucleotide	NULL
of	NULL
this	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

This	NULL
parsimonious	NULL
use	NULL
of	NULL
a	NULL
single	NULL
transcriptional	NULL
regulatory	NULL
element	NULL
may	NULL
be	NULL
important	NULL
in	NULL
allowing	NULL
T	NULL
cells	NULL
to	NULL
rigorously	NULL
control	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
potent	NULL
immunoregulatory	NULL
lymphokine	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Timothy	NULL
Hoey	NULL
and	NULL
Ya-Lin	NULL
Sun	NULL
(	NULL
Tu-larik	NULL
,	NULL
Inc.	NULL
)	NULL
for	NULL
performing	NULL
the	NULL
DNA	NULL
footprint	NULL
analysis	NULL
,	NULL
Richard	NULL
Goodman	NULL
for	NULL
suggestions	NULL
and	NULL
assistance	NULL
with	NULL
the	NULL
fluorescence	NULL
anisotropy	NULL
experiments	NULL
,	NULL
Katia	NULL
Georgopoulos	NULL
for	NULL
antibodies	NULL
and	NULL
murine	NULL
ATF-2	NULL
cDNAs	NULL
,	NULL
and	NULL
Laurie	NULL
Glimcher	NULL
(	NULL
Harvard	NULL
School	NULL
of	NULL
Public	NULL
Health	NULL
)	NULL
for	NULL
permission	NULL
to	NULL
cite	NULL
unpublished	NULL
data	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Locksley	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Wilson	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
in	NULL
Principles	NULL
and	NULL
Practice	NULL
of	NULL
Infectious	NULL
Diseases	NULL
(	NULL
Mandell	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Bennett	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
and	NULL
Dolin	NULL
,	NULL
R.	NULL
,	NULL
eds	NULL
)	NULL
Vol	NULL
.	NULL

1	NULL
,	NULL
4th	NULL
Ed	NULL
.	NULL

,	NULL
pp	NULL
.	NULL

102-149	NULL
,	NULL
Churchill-Livingstone	NULL
,	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
2	NULL
.	NULL

Seder	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12	NULL
,	NULL
685-673	NULL
3	NULL
.	NULL

Ullman	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Verweij	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8	NULL
,	NULL
421-452	NULL
4	NULL
.	NULL

Lewis	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Yu	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Meyer	NULL
,	NULL
J.	NULL
,	NULL
English	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
Kahn	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
Wilson	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

87	NULL
,	NULL
194-202	NULL
.	NULL

Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
15	NULL
,	NULL
274-281	NULL
.	NULL

Chuypilo	NULL
,	NULL
S.	NULL
,	NULL
Schomberg	NULL
,	NULL
C.	NULL
,	NULL
Gerwig	NULL
,	NULL
R.	NULL
,	NULL
Heinfling	NULL
,	NULL
A.	NULL
,	NULL
Reeves	NULL
,	NULL
R.	NULL
,	NULL
Grumnt	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Serfling	NULL
,	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21	NULL
,	NULL
5694-5704	NULL
7	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Perrino	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Soderling	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
8747-8752	NULL
8	NULL
.	NULL

Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Ho	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Chen	NULL
,	NULL
L.	NULL
,	NULL
Thomas	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Timmerman	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Admon	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
869	NULL
,	NULL
497-502	NULL
9	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Hoey	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
Immunity	NULL
2	NULL
,	NULL
473-483	NULL
10	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Sun	NULL
,	NULL
Y.	NULL
,	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
and	NULL
Hoey	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
6299-6310	NULL
11	NULL
.	NULL

Tsuruta	NULL
,	NULL
L.	NULL
,	NULL
Lee	NULL
,	NULL
H.-J	NULL
.	NULL

,	NULL
Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Koyano-Nakagawa	NULL
,	NULL
N.	NULL
,	NULL
Arai	NULL
,	NULL
N.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Yokata	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

154	NULL
,	NULL
5255-5264	NULL
12	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Hodge	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
625-633	NULL
13	NULL
.	NULL

Schreiber	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
18	NULL
,	NULL
186-142	NULL
14	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
Jacinto	NULL
,	NULL
E.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Kallunki	NULL
,	NULL
T.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Ben-Neriah	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cell	NULL
77	NULL
,	NULL
727-136	NULL
15	NULL
.	NULL

Boise	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
Petryniak	NULL
,	NULL
B.	NULL
,	NULL
Mao	NULL
,	NULL
X.	NULL
,	NULL
June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Wang	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
Lindsten	NULL
,	NULL
T.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
,	NULL
Kovary	NULL
,	NULL
K.	NULL
,	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
1911-1919	NULL
16	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Valge-Archer	NULL
,	NULL
V.	NULL
E.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
856	NULL
,	NULL
801-804	NULL
17	NULL
.	NULL

Szabo	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Gold	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Murphy	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
and	NULL
Murphy	NULL
,	NULL
K.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
4793-4805	NULL
18	NULL
.	NULL

Lederer	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Liou	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Todd	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
and	NULL
Lichtman	NULL
,	NULL
A.	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

152	NULL
,	NULL
77-86	NULL
19	NULL
.	NULL

Lewis	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Prickett	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Larsen	NULL
,	NULL
A.	NULL
,	NULL
Grabstein	NULL
,	NULL
K.	NULL
,	NULL
Weaver	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Wilson	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
9748-9747	NULL
20	NULL
.	NULL

Swain	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Bradley	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Croft	NULL
,	NULL
M.	NULL
,	NULL
Tonkonogy	NULL
,	NULL
S.	NULL
,	NULL
Atkins	NULL
,	NULL
G.	NULL
,	NULL
Weinberg	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Duncan	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Hedrick	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Dutton	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
and	NULL
Huston	NULL
,	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Control	NULL
of	NULL
IFN-y	NULL
Expression	NULL
Immunol	NULL
.	NULL

Rev	NULL
.	NULL

128	NULL
,	NULL
115-144	NULL
21	NULL
.	NULL

Penix	NULL
,	NULL
L.	NULL
,	NULL
Weaver	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Pang	NULL
,	NULL
Y.	NULL
,	NULL
Young	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
and	NULL
Wilson	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178	NULL
,	NULL
1483-1496	NULL
22	NULL
.	NULL

Young	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
Ghosh	NULL
,	NULL
P.	NULL
,	NULL
Ye	NULL
,	NULL
J.	NULL
,	NULL
Lederer	NULL
,	NULL
J.	NULL
,	NULL
Lichtman	NULL
,	NULL
A.	NULL
,	NULL
Gerard	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Penix	NULL
,	NULL
L.	NULL
,	NULL
Wilson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
Melvin	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
McGurn	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Lewis	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
and	NULL
Taub	NULL
,	NULL
D.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

153	NULL
,	NULL
3603-8610	NULL
28	NULL
.	NULL

Melvin	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
McGurn	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Bort	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Gibson	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Lewis	NULL
,	NULL
D.	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25	NULL
,	NULL
426-430	NULL
24	NULL
.	NULL

Sassone-Corsi	NULL
,	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
4717-4728	NULL
25	NULL
.	NULL

Burchett	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Weaver	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Westall	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Larsen	NULL
,	NULL
A.	NULL
,	NULL
Kronheim	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Wilson	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

140	NULL
,	NULL
8473-3481	NULL
26	NULL
.	NULL

Horton	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Cai	NULL
,	NULL
Z.	NULL
,	NULL
Ho	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
and	NULL
Pease	NULL
,	NULL
L.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
BioTechniques	NULL
8	NULL
,	NULL
528-535	NULL
27	NULL
.	NULL

Rebfuss	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Walton	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Loriaux	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Goodman	NULL
,	NULL
R.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
18481-18484	NULL
28	NULL
.	NULL

Walton	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Rebfuss	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Chrivia	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Lochner	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
and	NULL
Goodman	NULL
,	NULL
R.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

6	NULL
,	NULL
647-655	NULL
29	NULL
.	NULL

Georgopoulos	NULL
,	NULL
K.	NULL
,	NULL
Morgan	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Moore	NULL
,	NULL
D.	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
747-1757	NULL
30	NULL
.	NULL

Abdel-Hafiz	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
Heasley	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
Kyriakis	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Avruch	NULL
,	NULL
J.	NULL
,	NULL
Kroll	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Johnson	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
and	NULL
Hoeffler	NULL
,	NULL
J.	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

6	NULL
,	NULL
2079-2089	NULL
31	NULL
.	NULL

Abate	NULL
,	NULL
C.	NULL
,	NULL
Luk	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
3624-3632	NULL
32	NULL
.	NULL

Kerppola	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
5479-5489	NULL
33	NULL
.	NULL

Gentz	NULL
,	NULL
R.	NULL
,	NULL
Rauscher	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
III	NULL
,	NULL
Abate	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
248	NULL
,	NULL
1695-1699	NULL
34	NULL
.	NULL

Eustice	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Feldman	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Coberg-Poley	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Buckery	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Neubauer	NULL
,	NULL
R.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
BioTechniques	NULL
11	NULL
,	NULL
789-743	NULL
35	NULL
.	NULL

Fiering	NULL
,	NULL
S.	NULL
,	NULL
Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Mattila	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1823-1834	NULL
36	NULL
.	NULL

Ullman	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Flanagan	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Edwards	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
254	NULL
,	NULL
558-562	NULL
37	NULL
.	NULL

Abate	NULL
,	NULL
C.	NULL
,	NULL
Luk	NULL
,	NULL
D.	NULL
,	NULL
Gentz	NULL
,	NULL
R.	NULL
,	NULL
Rauscher	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
1082-1086	NULL
38	NULL
.	NULL

Hoeffler	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Meyer	NULL
,	NULL
T.	NULL
E.	NULL
,	NULL
Yun	NULL
,	NULL
Y.	NULL
,	NULL
Jameson	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Habener	NULL
,	NULL
J.	NULL
F.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
242	NULL
,	NULL
1430-1433	NULL
39	NULL
.	NULL

Turner	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
248	NULL
,	NULL
1689-1694	NULL
40	NULL
.	NULL

Stimac	NULL
,	NULL
E.	NULL
,	NULL
Lyons	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Pious	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
8734-3739	NULL
41	NULL
.	NULL

Ho	NULL
,	NULL
I.	NULL
C.	NULL
,	NULL
Vorhees	NULL
,	NULL
P.	NULL
,	NULL
Marin	NULL
,	NULL
N.	NULL
,	NULL
Oakley	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
Tsai	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
1187-1192	NULL
42	NULL
.	NULL

Dayton	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Knobloch	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
and	NULL
Benjamin	NULL
,	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Cytokine	NULL
4	NULL
,	NULL
454-460	NULL
43	NULL
.	NULL

Pang	NULL
,	NULL
Y.	NULL
,	NULL
Norihisa	NULL
,	NULL
Y.	NULL
,	NULL
Benjamin	NULL
,	NULL
D.	NULL
,	NULL
Kantor	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
and	NULL
Young	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
724-782	NULL
44.	NULL
de	NULL
Grazia	NULL
,	NULL
U.	NULL
,	NULL
Felli	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Vacca	NULL
,	NULL
A.	NULL
,	NULL
Farina	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Maroder	NULL
,	NULL
M.	NULL
,	NULL
Cappabianca	NULL
,	NULL
L.	NULL
,	NULL
Meco	NULL
,	NULL
D.	NULL
,	NULL
Farina	NULL
,	NULL
M.	NULL
,	NULL
Screpanti	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Frati	NULL
,	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180	NULL
,	NULL
1485-1497	NULL
45	NULL
.	NULL

Pfeuffer	NULL
,	NULL
I.	NULL
,	NULL
Klein-Hessling	NULL
,	NULL
S.	NULL
,	NULL
Heinfling	NULL
,	NULL
A.	NULL
,	NULL
Chuvpilo	NULL
,	NULL
S.	NULL
,	NULL
Escher	NULL
,	NULL
C.	NULL
,	NULL
Brabletz	NULL
,	NULL
T.	NULL
,	NULL
Hentsch	NULL
,	NULL
B.	NULL
,	NULL
Schwarzenbach	NULL
,	NULL
H.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Serfling	NULL
,	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
5572-5585	NULL
46	NULL
.	NULL

Ullman	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Admon	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
19983	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
188-196	NULL
47	NULL
.	NULL

Hai	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
8720-3724	NULL
48	NULL
.	NULL

Lee	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Chung	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
Liou	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Wu	NULL
,	NULL
M.	NULL
,	NULL
Li	NULL
,	NULL
W.	NULL
F.	NULL
,	NULL
Hsueh	NULL
,	NULL
Y.	NULL
P.	NULL
,	NULL
and	NULL
Lai	NULL
,	NULL
M.	NULL
Z	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
1906-1912	NULL
49	NULL
.	NULL

Benbrook	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Jones	NULL
,	NULL
N.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22	NULL
,	NULL
1463-1469	NULL
50	NULL
.	NULL

Ivashkiv	NULL
,	NULL
L.	NULL
B.	NULL
,	NULL
Liou	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
Kara	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Lamph	NULL
,	NULL
W.	NULL
W.	NULL
,	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
and	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
1609-1621	NULL
51	NULL
.	NULL

Kwok	NULL
,	NULL
R.	NULL
P.	NULL
S.	NULL
,	NULL
Lundblad	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Chrivia	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Richards	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Bachinger	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
Brennan	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Roberts	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
Green	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Goodman	NULL
,	NULL
R.	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
870	NULL
,	NULL
223-226	NULL
52	NULL
.	NULL

Gupta	NULL
,	NULL
S.	NULL
,	NULL
Campbell	NULL
,	NULL
D.	NULL
,	NULL
Derjard	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Davis	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Science	NULL
267	NULL
,	NULL
389-393	NULL
53	NULL
.	NULL

Cippitelli	NULL
,	NULL
M.	NULL
,	NULL
Sica	NULL
,	NULL
A.	NULL
,	NULL
Viggiano	NULL
,	NULL
V.	NULL
,	NULL
Ye	NULL
,	NULL
J.	NULL
,	NULL
Ghosh	NULL
,	NULL
P.	NULL
,	NULL
Birrer	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Young	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
12548-12556	NULL
54	NULL
.	NULL

Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Ullman	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
2917-2923	NULL
55.	NULL
van	NULL
Dam	NULL
,	NULL
H.	NULL
,	NULL
Duyndam	NULL
,	NULL
M.	NULL
,	NULL
Rottier	NULL
,	NULL
R.	NULL
,	NULL
Bosch	NULL
,	NULL
A.	NULL
,	NULL
de	NULL
Vries-Smits	NULL
,	NULL
L.	NULL
,	NULL
Herrlich	NULL
,	NULL
P.	NULL
,	NULL
Zantema	NULL
,	NULL
A.	NULL
,	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
van	NULL
der	NULL
Eb	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
479-487	NULL
56	NULL
.	NULL

Feuerstein	NULL
,	NULL
N.	NULL
,	NULL
Huang	NULL
,	NULL
D.	NULL
,	NULL
Hinrichs	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
Orten	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Aiyar	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Prystowsky	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

154	NULL
,	NULL
68-79	NULL
57	NULL
.	NULL

Hilkins	NULL
,	NULL
C.	NULL
M.	NULL
U.	NULL
,	NULL
Vermeulen	NULL
,	NULL
H.	NULL
,	NULL
Joost	NULL
van	NULL
Neerven	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Snijdewint	NULL
,	NULL
F.	NULL
G.	NULL
M.	NULL
,	NULL
Wierenga	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
and	NULL
Kapsenberg	NULL
,	NULL
M.	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25	NULL
,	NULL
59-63	NULL
58	NULL
.	NULL

Betz	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Fox	NULL
,	NULL
B.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

146	NULL
,	NULL
108-113	NULL
59	NULL
.	NULL

Novak	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
and	NULL
Rothenberg	NULL
,	NULL
E.	NULL
V.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
9353-9357	NULL
60	NULL
.	NULL

Katamura	NULL
,	NULL
K.	NULL
,	NULL
Shintaku	NULL
,	NULL
N.	NULL
,	NULL
Yamauchi	NULL
,	NULL
Y.	NULL
,	NULL
Fukui	NULL
,	NULL
T.	NULL
,	NULL
Ohshima	NULL
,	NULL
Y.	NULL
,	NULL
Mayumi	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Furusho	NULL
,	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

155	NULL
,	NULL
4604-4612	NULL
61	NULL
.	NULL

Bird	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
70	NULL
,	NULL
5-8	NULL
62	NULL
.	NULL

Meehan	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Lewis	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Bird	NULL
,	NULL
A.	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
5085-5092	NULL
63	NULL
.	NULL

Weih	NULL
,	NULL
F.	NULL
,	NULL
Nitsch	NULL
,	NULL
D.	NULL
,	NULL
Reik	NULL
,	NULL
A.	NULL
,	NULL
Schutz	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Becker	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
2559-2567	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
The	NULL
Proximal	NULL
Regulatory	NULL
Element	NULL
of	NULL
the	NULL
Interferon-y	NULL
Promoter	NULL
Mediates	NULL
Selective	NULL
Expression	NULL
in	NULL
T	NULL
Cells	NULL
Laurie	NULL
A.	NULL
Penix	NULL
,	NULL
Marianne	NULL
T.	NULL
Sweetser	NULL
,	NULL
William	NULL
M.	NULL
Weaver	NULL
,	NULL
James	NULL
P.	NULL
Hoeffler	NULL
,	NULL
Tom	NULL
K.	NULL
Kerppola	NULL
and	NULL
Christopher	NULL
B.	NULL
Wilson	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1996	NULL
,	NULL
271:31964-31972.	NULL
doi	NULL
:	NULL
10.1074/jb0.271.50.31964	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/271/50/31964	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
63	NULL
references	NULL
,	NULL
35	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

